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ABSTRACT

Survival analysis today is widely implemented in the fields of medical and biological
sciences, social sciences, econometrics, and engineering. The basic principle behind the survival
analysis implies to a statistical approach designed to take into account the amount of time
utilized for a study period, or the study of time between entry into observation and a subsequent
event. The event of interest pertains to death and the analysis consists of following the subject
until death. Events or outcomes are defined by a transition from one discrete state to another at
an instantaneous moment in time. In the recent years, research in the area of survival analysis has
increased greatly because of its large usage in areas related to biosciences and the pharmaceutical
studies. After identifying the probability density function that best characterizes the tumors and
survival times of breast cancer women, one purpose of this research is to compare the efficiency
between competing estimators of the survival function. Our study includes evaluation of
parametric, semi-parametric and nonparametric analysis of probability survival models.
Artificial Neural Networks (ANNs), recently applied to a number of clinical, business,
forecasting, time series prediction, and other applications, are computational systems consisting
of artificial neurons called nodes arranged in different layers with interconnecting links. The
main interest in neural networks comes from their ability to approximate complex nonlinear
functions. Among the available wide range of neural networks, most research is concentrated
around feed forward neural networks called Multi-layer perceptrons (MLPs). One of the
xii

important components of an artificial neural network (ANN) is the activation function. This work
discusses properties of activation functions in multilayer neural networks applied to breast cancer
stage classification. There are a number of common activation functions in use with ANNs. The
main objective in this work is to compare and analyze the performance of MLPs which has backpropagation algorithm using various activation functions for the neurons of hidden and output
layers to evaluate their performance on the stage classification of breast cancer data.
Survival analysis can be considered a classification problem in which the application of
machine-learning methods is appropriate. By establishing meaningful intervals of time according
to a particular situation, survival analysis can easily be seen as a classification problem. Survival
analysis methods deals with waiting time, i.e. time till occurrence of an event. Commonly used
method to classify this sort of data is logistic regression. Sometimes, the underlying assumptions
of the model are not true. In model building, choosing an appropriate model depends on
complexity and the characteristics of the data that affect the appropriateness of the model. Two
such strategies, which are used nowadays frequently, are artificial neural network (ANN) and
decision trees (DT), which needs a minimal assumption. DT and ANNs are widely used
methodological tools based on nonlinear models. They provide a better prediction and
classification results than the traditional methodologies such as logistic regression. This study
aimed to compare predictions of the ANN, DT and logistic models by breast cancer survival. In
this work our goal is to design models using both artificial neural networks and logistic
regression that can precisely predict the output (survival) of breast cancer patients. Finally we
compare the performances of these models using receiver operating characteristic (ROC)
analysis.

xiii

CHAPTER ONE
Introduction
1.1 Cancer
In modern medicine, the term tumor means a neoplasm (from Ancient
Greek νεο- neo- "new" and πλάσμα plasma “formation, creation” in field medicine) is an
abnormal mass of tissue as a result of uncontrolled growth or division of cells. Some neoplasms
do not cause a lump or form an additional tissue. They are called benign. Cancer is
a malignant neoplasm or malignant tumor. This malignant neoplasm or tumor is the largest cause
for death in United States Cancer. Cancer is not a new disease from the present generation, it has
been documented and recorded on a papyrus from ancient Egypt, in 1500 B.C. This oldest
document has details that were recorded on a papyrus, documenting 8 cases of tumors occurring
on the breast. Further descriptions can be found in ancient writings of Chinese and Arabic
literature.
As mentioned earlier, cancer is a condition of abnormal and rapid cell destruction inside
the tissues making a mass of extra tissues which is known as tumor. The cancer disease is
majorly classified into two types based on the tissue or tumor growth. Benign and malignant.
Unlike benign tumors which are assumed not harmful, malignant tumors are formed by jumping
of cancer cells to other parts of the body. Scientists have stated the reason behind formation of
such condition is due to adhesion property of the cancer causing cells which is stated as the
metastasis. The major types of cancers are breast cancer (in women), leukemia (in children),
1

prostate cancer (in men) and colon cancer. Our present dissertation deals with the subject of
breast cancer in women with condition of malignancy. Table 1.1 below gives a brief statistics of
estimated deaths of different types of cancers observed in women during 2013 (Source:
American Cancer Society).
Table 1.1: Summary of major cancers in women

Different types of cancers in

Percentages

women
Lung & Bronchus

72,220 (26%)

Breast

39,620 (14%)

Colon & Rectum

24,530 (9%)

Pancreas

18,980 (7%)

Ovary

14,030 (5%)

Non-Hodgkin Lymphoma

8,430 (3%)

Leukemia

10,060 (4%)

Uterine corpus

8,190 (3%)

Liver & intrahepatic bile duct

6,780 (2%)

Brain/Other nervous systems

6,150 (2%)

All sites

273,430 (100%)

1.2 Breast Cancer
Breast has been considered as a symbol of femininity, fertility and beauty. Breast disease
has been known to mankind since old times. Due to the unmistakable side effects particularly at
later stages, the bumps that advance into tumors have been recorded by doctors promptly in time.
Unlike other inside malignancies, bosom bumps have a tendency to show themselves as
noticeable tumors.

2

Breast cancer is the most common effecting disease in women and second most cause of
death for women in United States. It is the cancer that starts in the tissues of the breast with
uncontrolled multiplicity affects other parts of the body causing death. There are certain cases of
breast cancer observed in men, but it accounts for less than 0.05% of all the cases diagnosed.
Breast cancer is classified into two main types:


Ductal carcinoma: starts in the tubes (ducts) that move milk from the breast to the
nipple. Most of the cases fall under this breast cancer.



Lobular carcinoma: starts in parts of the breast, called lobules that produce milk.

In very rare cases, breast cancer can start in other areas of the breast. According to
American Cancer Society (ACS), even at the age of 85 one in eight women are diagnosed with
breast cancer. In 2013, an estimated 232,340 new cases of invasive breast cancer are expected to
be diagnosed among the women, and about 2240 new cases are expected in men. In addition to
this facts, 64,640 new cases of the in situ breast cancer are expected in the women; of which 85%
approximately fall into category of ductal carcinoma. One good thing about breast cancer is that
it can be treated if it is detected in early stages. The most common outward signs of detection are
formation of lumps, or nipple tenderness or thickening of area near the breasts or a dimple in the
breast. Less commonly observed signs include breast swelling and enlarged underarm area. The
important risk factors include gender, age, family history, early menarche, late menopause,
physical inactivity, alcohol consumption, among many others. Other clinical factors for increase
in risk are high bone mineral density, biopsy confirmed hyperplasia, high dose radiation to the
chest, long menstrual history etc.

3

1.3 Survival Analysis
Survival analysis today is implemented in almost all fields of sciences. An analysis which
is performed to determine the probability of occurrence of the events associated with death or
failure after treatment to the subjects is termed as survival analysis. This classification is
applicable with help of machine- learning methods that evolve categorical results with
predetermined time intervals. Survival analysis of breast cancer has acquired good importance
for cancer detection in early stages taking into consideration risk factors. Different kinds of
survival studies in present day include clinical trials, prospective cohort studies, retrospective
cohort studies and retrospective correlative studies. Survival analysis deals with time to event
modeling data with censoring. Censoring is mechanism of identification of the data values
which do not follow up until end of the experiment. In many cases data considered for survival
analysis are right censored which implies that the concerned subjects leaves the study before the
event has occurred or study ends before the event has occurred. The primary interest is to
investigate the time to event or the survival probability. The statistical methods employed in
study of survival and hazard probability can be performed parametrically, semi-parametrically
and non-parametrically based on the nature of the data.
1.3.1 Non-Parametric, Parametric and Semi-parametric Analyses
Non-parametric survival analysis is used to analyze the data avoiding assumptions for the
underlying distributions. This kind of analysis restricts the data from occurrence of potential
errors. One of the commonly used non-parametric estimator is Kaplan-Meier estimator also
called as product limit estimator. The plots of product limit estimator is a graph with declining
steps. At times censoring data predicts more accurate results with product limit estimator.

4

Parametric survival analysis assumes functional form of probability distribution for the
variables that provides the influence of explanatory variables on survival time. The strength of
this analysis is the estimation is relatively easy and survival curves are smoother as they draw
information from whole data. This parametric analysis is carried out using two different
approaches which are regression parametric models (Accelerated Failure Time models) and
Proportional Hazard (PH models). The name ‘accelerated life’ is extracted from the industrial
applications where the items are subjected to worse conditions than the item usually encounter in
real life, so that the experiment is completed in short period of time. Acceleration Failure models
are usually applied to the log of the survival time. Different AFT models are generated by
assuming different distributions to error term of expression. Estimation of such models using the
maximum likelihood is computed for the censored data.
The intermediate model between above two analyses is semi-parametric survival analysis
or Cox-regression analysis. It overcomes the disadvantage of the non-parametric analysis of
comparing the survival functions for limited number of groups. Cox regression models or PH
models are used for the survival time estimation making assumptions to hazard function in the
formula. Distribution for the baseline hazard are assumed to follow exponential, Weibull, lognormal, log-logistic or generalized gamma. Even though cox models have driven statistical
innovations in past decades, there is more to come in future.
1.4 Logistic Regression
Logistic regression is mostly used to predict a categorical (usually dichotomous) variable
from a given set of independent variables. If all the independent variables are continuous, we
usually employ discriminant analysis for modeling the data. In case if all or few independent
5

variables are categorical, logistic regression analysis is the best choice. Also on the other hand,
logistic regression makes no assumptions about the distributions of the independent
variables. One of the most commonly used tools of medical and clinical applied statistics and
discrete data analysis is logistic regression. It is put forward around 1940’s against the Fisher’s
1936 classification method and considered as center part of many research studies. Logistic
regression also finds applications in the fields of engineering, opinion polls, marketing etc.
In logistic regression, the predicted dependent variable is a function of the probability
that a particular subject will be in one of the categories (two categories in case of dichotomous
dependent variable). In other words, logistic regression is used to predict the probability that the
'event of interest' will occur as a function of one (or more) discrete/continuous and/or
dichotomous independent variables (either 0 or 1). For example identifying the relationship
between a binary outcome (dependent) variable such as presence or absence of disease when we
are given with predictor (explanatory or independent) variables such as patient demographics or
imaging findings. The important difference between what is being estimated by a logistic
regression model and that estimated by a linear model is that linear regression attempts to predict
the value of the dependent variable as a linear function of one or more independent variables.
Whereas logistic regression attempts to predict the probability that a unit under analysis will
acquire the event of interest as a function of one or more independent variables.
1.5 Artificial Neural Networks
The implementation of artificial neural networks (ANNs) in the field of survivability is
suggested to address the limitations of traditional regression methods. ANNs are algorithms
which are patterned after the structure of human brain. They possess series of mathematical
6

equations and terms to simulate the biological process such as learning and memory. Neural
networks offers the ability to detect the complex nonlinear relationships between dependent and
independent variables. ANNs find applications in the fields of social sciences, clinical studies,
Financial models, altitudes in educational sciences, social mobility, travel behavior, social capital
among many others. A basic neural network consists of input, hidden and output layers. The
interconnected nodes in different layers possess weights which are adjusted to find the most
reliable outcomes by a process termed as learning or training. The most commonly used neural
network is multilayer perceptron which consists of one input, one output and one or more hidden
layers. The principle of MLP is to reduce the discrepancy between the real and predicted
outcomes by propagating discrepancy in backward direction. The merits of trained ANNs is the
capability to elevate the information present in the hidden layers without the effect of constraints
on the data representation. Limitations of ANNs include its black box nature, greater
computation burden, and proneness to over fitting etc. Due to its effective analysis of more
complex data, ANNs are used to analyze non-linear covariates, time dependent covariates and
versatility among high order covariates. Comparing to traditional regression models ANNs have
provided better results concerning to the cancer research.
1.5.1 ANN and Statistics
The artificial neural network (ANNs) and literature in statistics discusses almost same
concepts but usually with different terminology. Sometimes the same term in these both
literatures may have a different meaning. Below in the Table 1.2 we have mentioned few of such
terms used in both the cases.
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1.6 Linking ANN, Logistic Regression and Survival analysis
Survival analysis methods deals with waiting time, i.e. time till occurrence of an event.
Commonly used method to classify this sort of data is logistic regression. However, sometimes
the underlying assumptions of the model may not be true. In model building, choosing an
appropriate model depends on complexity and the characteristics of the data that effect the
appropriateness of the model. One strategy, which is used nowadays frequently, is artificial
neural network (ANN) model which needs a minimal or no assumptions. My current research is
aimed to compare survival models and predictions of the ANN models for stage classification,
survival and logistic modeling for breast cancer survival.
Table 1.2: ANN and Statistical jargon

Neural networks
Architecture
Inputs
Outputs
Connection weights
Bias weight
Error
Supervised learning
Unsupervised
learning
Training set
Testing set
Learning, training
Training case, pattern
Cross-entropy
Classification
Activation function
Epoch

Statistics
Model
Independent (predictor)
variable
Dependent (outcome) variable,
predicted value
Regression coefficients
Intercept parameter
Residuals
Regression, discriminant
analysis
PCA, Data reduction,
Clustering
Sample data
Hold-out data
Parameter estimation, fitting
Observation
Maximum likelihood
estimation
Discriminant analysis
Inverse link function in GLIM
Iteration
8

CHAPTER TWO
Parametric Analysis of Breast Cancer Tumor Sizes

2.1 Introduction
Any cancer that grows in our body is always dangerous. If it exists one must try to locate
and get it out of our body immediately. Breast cancer is a signature disease of Western
populations. Breast cancer is a cancer that starts in the tissues of the breast. There are two main
types of breast cancer. Ductal carcinoma starts in the tubes (ducts) that move milk from the
breast to the nipple. Most breast cancers are of this type. Lobular carcinoma starts in parts of the
breast, called lobules that produce milk (1 –3). In very rare cases, breast cancer can start in other
areas of the breast. The three most important things that we can do to find a growth in the breast
that may become malignant are: regularly scheduled mammograms, annual clinical breast exams
with your health practitioner, and monthly breast self-examination (4).

2.2 Facts and Numbers
Cancer is a major cause of morbidity in the United States, with a total of 1.34 million
cases reported during 2005 from 49 of the 50 states (5). According to American Cancer Society
(ACS), about 1 in 8 women in the United States (12%) will develop invasive breast cancer over
the course of her lifetime (6). In 2016, an estimated 246,660 new cases of invasive breast
cancer (includes new cases of primary breast cancer among survivors, but not recurrence of
original breast cancer among survivors) are expected to be diagnosed in women in the U.S.,
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along with 61,000 new cases of non-invasive (in situ) breast cancer and an estimated deaths due
to breast cancer would be around 40,450 (6, 7).
About 2,600 new cases of invasive breast cancer were expected to be diagnosed in men in
2016. Less than 1% of all new breast cancer cases occur in men. For women in the U.S., breast
cancer death rates are higher than those for any other cancer, besides lung cancer. Also besides
skin cancer, breast cancer is the most commonly diagnosed cancer among U.S. women. More
than 1 in 4 cancers in women (about 28%) are effected with breast cancer.
2.3 Questions of Interest
Q1: What is the probability distribution function (PDF) that best characterizes the
behavior of malignant tumors for Whites, African Americans and other races?
Q2: Is there any statistical difference between mean tumor sizes between the three races
(Whites, African Americans and Others) in the study?
Q3: Is there any statistical difference between mean tumor sizes of any two races?
Q4: If a lady feels a tumor while self-examining, what is the confidence interval
estimation for the average tumor size based on her race?
2.4 Data Description
The Surveillance, Epidemiology, and End Results (SEER)-Medicare database links data
from the National Cancer Institute’s SEER cancer registry program with claims data from
Medicare, the federally funded insurance program for the US elderly. These data are made
available to investigators and have been used extensively in research (details at
http://healthservices.cancer.gov/seermedicare/). This resource is valuable for conducting research
on cancers. (8-14)
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SEER is a National Cancer Institute-funded program collecting data on cancer incidence
and survival from US cancer registries (http://www.seer.cancer.gov). SEER began in 1973 with 9
state and metropolitan area cancer registries. Successive expansions in 1992 and 2001 led to the
inclusion in SEER of 17 cancer registries that presently cover approximately 26%of the US
population. In total, 146 million person-years are covered during 1973–2007, with 3.1 million
incident cancers on the basis of a positive or negative test. The US National Cancer Institute’s
Surveillance, Epidemiology, and End Results (SEER) program began collecting the data for
many cancers in almost 17 registries.
We obtained breast cancer incidence data from the US National Cancer Institute’s SEER
program. We used patient and population data from the SEER 9 Registries Database (15, 16) the
information that we have used in this present study is obtained from SEER database registry.
This data source SEER (16) (Surveillance Epidemiology and End Results), which is a unique,
reliable and essential resource for investigating the different aspects of cancer. The SEER
database combines patient-level information on cancer site, tumor pathology, stage, and cause of
death (3, 4).
In this work, we preprocessed the SEER data (period of 1992-2008 with all records
named in breast.txt) for breast cancer to remove redundancies and missing information. The
resulting data set had 47,167 malignant tumor records, which then pre-classified into three
groups of races. “Whites” (37,341; 79.15%), “African American” (4,234; 9%) and “Others”
(5,592; 11.85%) are given in Table 2.1.
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Table 2.1 Race and age details

Race

N

Percent

1
2
3

37341
4234
5592

79.17
8.98
11.86

Minimum
age
21
22
21

Median age
62
57
53

Maximum
age
102
102
99

In this work, demographic information included age, race, and marital status. Tumor
characteristics like tumor size (1mm to 998mm), stage of cancer (I, II, III, IV), tumor grade (1, 2,
3, 4, or unknown), and tumor treatment (1, 2, 3, 4) are included.
From Table 2.1, median age at diagnosis in the White women is 62 years (range 21 to
102 years) compared with a median age of 57 years in the African American women (range 22 to
102 years) and a median age of 53 years in the Other races women (range 21 to 99 years). There
are 62.15% survival and 37.35% of not survived patients in our data (Table 2.2) and from Table
2.3, majority of patients (about 92%) are diagnosed when they are in stages 1 and 2 and very few
(about 8%) of them are diagnosed in advanced stage of breast cancer.

Table 2.2 Survival status details

Status

Frequency Percent

Dead (0)
Survived (1)

17853
29314

37.85
62.15

Cumulative
percent
37.85
100.00

Table 2.3 Breast cancer stage wise details

Stage

Frequency Percent

1
2
3
4

23345
20017
2600
1205

49.49
42.44
5.51
2.55

12

Cumulative
percent
49.49
91.93
97.45
100.00

Total Malignant
Tumors

Women

Men

Race = African Americans (9%)

Stop
Race = Whites (79%)

Race = Others (12%)

Figure 2.1 Race wise tumor classification chart

2.5 Parametric Analysis of tumor size
Most clinical research involves the collection of some form of quantitative data. The
purpose of collecting data is to obtain information that will allow one to infer or draw
conclusions about the specific characteristics of a certain large group of subjects or events based
on the observation of a few (17 - 20).To select the proper statistical test it is important to know
how the data are distributed. The word parametric, or parameter, relates to the nature of data, i.e.,
the assumptions about particular data. The primary assumptions are that the data points are
randomly drawn, that the population is normally distributed and that there is homogeneity among
variances. Parametric tests are more stringent than nonparametric tests, and the results tend to be
more powerful.
In our work we performed parametric analysis to determine the best fitted distribution
that characterizes the behavior of tumor size for each race by setting the hypothesis as follows:
𝐻0 : 𝑇ℎ𝑒 𝑡𝑢𝑚𝑜𝑟 𝑠𝑖𝑧𝑒 𝑑𝑎𝑡𝑎 𝑓𝑜𝑙𝑙𝑜𝑤𝑒𝑑 𝑎 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑝𝑎𝑟𝑎𝑚𝑒𝑡𝑟𝑖𝑐 𝑚𝑜𝑑𝑒𝑙
𝐻1 : 𝑇ℎ𝑒 𝑡𝑢𝑚𝑜𝑟 𝑠𝑖𝑧𝑒 𝑑𝑎𝑡𝑎 𝑑𝑖𝑑 𝑛𝑜𝑡 𝑓𝑜𝑙𝑙𝑜𝑤 𝑎 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑝𝑎𝑟𝑎𝑚𝑒𝑡𝑟𝑖𝑐 𝑚𝑜𝑑𝑒𝑙
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After performing many trials, from the class of many parametric distributions, based on
the results of minimum Anderson-Darling value, we identified that Inverse Gaussian distribution
as the best probabilistic distribution function that characterizes the behavior of the malignant
tumors for all the three races considered in this study.

2.5.1 Inverse Gaussian distribution
Over a century, family of Inverse Gaussian distributions had attracted the attention of
many researchers in many fields (21). When the data possess some extreme values in it, we need
a distribution that can take all the values into consideration, one such is Inverse Gaussian
distribution. This is also known as Inverse normal distribution or Wald distribution. Inverse
Gaussian distribution is 2-parameter family of continuous probability functions with support on
(0, ∞). This distribution is derived while observing the Brownian motion i.e., random movements
of atoms and molecules by Schrodinger in 1915 (23).
The Hazard rate function of Inverse Gaussian distribution is uni-modal which increases
from zero to its maximum value and decreases asymptotically to a constant. The most
differentiating fact is extreme values of outcomes can occur with almost all outcomes being
small. It is a right-skewed distribution with long tail. For these reasons Inverse Gaussian
distribution is often used in reliability and survival analysis. Various insurance problems and
stock markets follow this distribution (22).
The distribution is described by two parameters. Mean or location (µ > 0) and precision
or shape (λ > 0). Let us suppose x1, x2, x3… xn be n independent and random variables. If xi
follows the inverse Gaussian distribution, then probability density function of𝑥𝑖 ~ 𝐼𝐺 (µ, 𝜆) is
1

𝜆 2
𝜆(𝑥 − 𝜇)2
𝑓(𝑥, 𝜃) = (
) 𝑒𝑥𝑝 {−
} , 𝑥 ≥ 0; 𝜃 = (𝜇, 𝜆)𝑇
3
2
2𝜋𝑥
2𝜇 𝑥
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𝜇3

The expected value is given by mean µ and variance is equal to 𝜆 . The cumulative distribution
function is given by

𝐹(𝑦) = 𝜙(𝑦) + exp (

W

2𝜆
4𝜆
) (−√ + 𝑦 2 ) ; −∞ < 𝑦 < ∞
𝜇
𝜇
𝜆

is the standard normal distribution function. Clearly, as𝜇 → ∞, 𝐹(𝑦) → 𝜙(𝑦). The

confidence interval for true mean of this distribution is given by 𝜇̂ ± 𝑧𝛼⁄2 (𝑛𝜆)−1⁄2 𝜇̂ 3⁄2

2.5.2 PDF for White women

Figure 2.2 PDF for white women: Inverse Gaussian Distribution

The fitted PDF and CDF of tumor sizes for white race women is
1

43.93 2
43.93(𝑥 − 32.76)2
𝑓(𝑥, 𝜃) = (
)
𝑒𝑥𝑝
{−
} , 𝑥 ≥ 0;
2𝜋𝑥 3
2(32.76)2 𝑥
𝐹(𝑦) = 𝜙(𝑦) + exp(2.682) (−√5.36 + 𝑦 2 )
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Figure 2.3 Inverse Gaussian CDF for White Women

Figure 2.4 Inverse Gaussian PP Plot for White Women

Figure 2.2 is the fitted Inverse Gaussian PDF with estimated shape and location
parameters as 43.933 and 32.756 respectively. From Figure 2.3 the CDF graph explains how well
the distribution fit to data and the PP plot in Figure 2.4 is approximately linear and confirms
about the fitted distribution.
16

2.5.3 PDF for African American women
Figure 2.5 below is the fitted Inverse Gaussian PDF for AA women with estimated shape
and location parameters as 66.614 and 39.611 respectively. From Figure 2.6 the CDF graph
explains how well the distribution fits to data and the PP plot in Figure2.7 is approximately
linear and confirms about the fitted distribution.

Figure 2.5 PDF for African American Women: Inverse Gaussian distribution

The fitted PDF and CDF of tumor sizes for African American race women is
1

66.61 2
66.61(𝑥 − 39.61)2
𝑓(𝑥, 𝜃) = (
)
𝑒𝑥𝑝
{−
} , 𝑥 ≥ 0;
2𝜋𝑥 3
2(39.61)2 𝑥
𝐹(𝑦) = 𝜙(𝑦) + exp(3.363) (−√6.73 + 𝑦 2 )
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Figure 2.6 Inverse Gaussian CDF for African American Women

Figure 2.7 Inverse Gaussian PP Plot for African American Women
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2.5.4 PDF for Other Races
Figure 2.8 below is the fitted Inverse Gaussian PDF for other race women with estimated shape
and location parameters as 55.703 and 36.846 respectively. From Figure 2.9 the CDF graph
explains how well the distribution fit to data. The fitted PDF and CDF of tumor sizes for other
race women is
1

55.70 2
55.70(𝑥 − 36.85)2
𝑓(𝑥, 𝜃) = (
)
𝑒𝑥𝑝
{−
} , 𝑥 ≥ 0;
2𝜋𝑥 3
2(36.85)2 𝑥
𝐹(𝑦) = 𝜙(𝑦) + exp(3.02) (−√6.05 + 𝑦 2 )

Figure 2.8 PDF for Other races: Inverse Gaussian Distribution
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Figure 2.9 Inverse Gaussian CDF for Other race women

2.5.5 Summary of PDF’s

Table 2.4 PDF summary for three races

RACE

𝝀̂

𝝁
̂

White

43.933

32.756

African American

66.614

39.611

Others

55.703

36.846

Table 2.5 has the race wise details of 95% and 99% confidence interval estimation of true
mean tumor size based on Inverse Gaussian distribution. After identifying the distribution
functions that best characterizes the probability distribution of malignant tumors for the three
races, we proceed to compare the differences of mean tumor sizes for the three races.
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Table 2.5 The mean tumor size and confidence intervals of all the three races

𝝁
̂

𝝀̂

1

32.756

2
3

Race

SD

95% CI for 𝝁

99% CI for 𝝁

43.933

28.284

(32.47, 33.04)

(32.38, 33.13)

39.611

66.614

30.545

(38.69, 40.53)

(38.40, 40.82)

36.846

55.703

29.967

(36.06, 37.63)

(35.81, 37.88)

2.6 Comparison of mean tumor sizes
Let 𝜇𝑤 , 𝜇𝑎𝑎 , 𝑎𝑛𝑑 𝜇𝑜𝑡ℎ represent mean tumor sizes of whites, African Americans and other
races respectively. Our interest is to test the hypothesis whether all the three races have same
mean tumor size or otherwise.
𝐻0 : 𝜇𝑤 = 𝜇𝑎𝑎 = 𝜇𝑜𝑡ℎ 𝑣𝑠. 𝐻1 : 𝐴𝑡 𝑙𝑒𝑎𝑠𝑡 𝑜𝑛𝑒 𝑜𝑓 𝑡ℎ𝑒𝑚 𝑖𝑠 𝑛𝑜𝑡 𝑒𝑞𝑢𝑎𝑙.
By performing a one way ANOVA at 5% level of significance, we obtained the p-value
which is very low(p < 0.0001); leading us to the conclusion that there is significant difference
between the average tumor sizes of all the three races. So, we now proceed in pair wise testing of
mean tumor sizes for all three races. The Table2.6 below has the details of the results after
performing t-test for pair wise testing. Clearly, we conclude that the average tumor size is
significantly different for all the three races in this study.

Table 2.6 Pair wise comparison of mean tumor sizes

95% CI for mean

HNull

HAlternative

P-value

Conclusion

𝜇𝑤 = 𝜇𝑎𝑎

𝜇𝑤 not equals 𝜇𝑎𝑎

0.001

Reject Null

(8.107, 8.659)

𝜇𝑎𝑎 = 𝜇𝑜𝑡ℎ

𝜇𝑎𝑎 not equals 𝜇𝑜𝑡ℎ

0.0001

Reject Null

(-10.191, -7.760)

𝜇𝑤 = 𝜇𝑜𝑡ℎ

𝜇𝑤 not equals 𝜇𝑜𝑡ℎ

0.0002

Reject Null

(-18.547, -16.171)
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differences

Previous studies (24 - 26) have shown that breast cancer in these younger women is more
aggressive, with higher rate of occurrence and recurrence rates compared with older women. In
our study we have the median age of women for all the three races more than 50 years. In Table
2.7, we classified the tumor stage taking age group into consideration. The majority of women
are in the ages from 45 to 79. From Table 2.8 and Figure 2.11, African American women are the
majority of population in all the age groups who are diagnosed with breast cancer. Table 2.8
gives the age group wise confidence interval for mean tumor size for all the three races. Very
interestingly, from Figure 2.10 majority of women in younger ages (20 – 44 years) are identified
with stage-2 breast cancer.
Table 2.7 Age group Vs. Stage classification

AGE

Stage 1

Stage 2

Stage 3

Stage 4

All

Count Row% Count Row% Count Row% Count Row% Total
20-24

7

25.93

17

62.96

3

11.11

0

0.00

27

25-29

67

26.59

152

60.32

25

9.92

8

3.17

252

30-34

239

27.86

481

56.06

94

10.96

44

5.13

858

35-39

700

34.08

1157

56.33

152

7.40

45

2.19

2054

40-44

1456

37.89

1992

51.83

305

7.94

90

2.34

3843

45-49

2153

41.54

2560

49.39

348

6.71

122

2.35

5183

50-54

2561

45.78

2546

45.51

342

6.11

145

2.59

5594

55-59

2634

50.44

2209

42.30

250

4.79

129

2.47

5222

60-64

2723

53.92

1999

39.58

209

4.14

119

2.36

5050

65-69

2909

56.58

1892

36.80

199

3.87

141

2.74

5141

70-74

2997

59.35

1755

34.75

169

3.35

129

2.55

5050

75-79

2496

58.03

1509

35.08

199

4.63

97

2.26

4301

80-84

1526

55.49

993

36.11

143

5.20

88

3.20

2750

85+

877

47.61

755

40.99

162

8.79

48

2.61

1842

All

23345 49.49

2600

5.51

1205

2.55

47167

20017 42.44
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Stage 1

Stage 2

Stage 3

Stage 4

100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%

Figure 2.10 Stages vs. age group

Table 2.8 Age group based race wise confidence interval of tumor sizes
Age
Group

Race 1

Race 2

Mean

S.D

20-24

27.12

25-29

C.I (95%)

Race 3

Mean

S.D

L.C.I

U.C.I

15.75

19.40

34.84

26.86

33.53

74.51

22.70

44.36

30-34

36.24

82.99

29.51

35-39

29.44

60.16

40-44

27.79

45-49

C.I (95%)

Mean

S.D

L.C.I

U.C.I

13.67

16.73

36.99

18.5

56.2

162.8

3.02

109.38

42.97

46.8

124.2

24.94

26.36

32.52

28.46

22

59.2

25.58

30.00

40.23

27.81

70.22

25.57

30.05

50-54

25.06

62.78

23.15

55-59

24.44

68.85

60-64

22.20

65-69

C.I (95%)
L.C.I

U.C.I

3.32

15.25

21.75

54.2

167.6

-2.14

110.54

68.66

28.55

22.25

24.99

32.11

25.57

31.35

39.19

114.91

27.37

51.01

110.44

29.35

51.11

26.84

55.2

22.74

30.94

35.8

89.67

27.88

43.72

27.11

67.33

22.71

31.51

26.96

36.92

95.54

28.89

44.95

24.01

38.44

21.44

26.58

22.31

26.57

28.56

64.53

23.03

34.09

23.81

55.75

19.62

28.00

59.49

20.36

24.04

26.27

51.07

21.63

30.91

22.21

44.1

18.58

25.84

23.03

67.36

20.99

25.07

35.11

104.32

25.51

44.71

19.52

16.65

18.05

20.98

70-74

20.41

53.55

18.81

22.00

30.67

78.75

22.47

38.87

29.45

101.49

19.18

39.72

75-79

21.31

48.48

19.75

22.86

34.58

98.68

23.52

45.64

19.84

14.66

18.10

21.58

80-84

22.65

51.02

20.62

24.68

26.81

21.21

23.79

29.83

21.89

25.49

17.49

26.29

85+

29.43

73.19

25.91

32.95

30.42

23.38

26.20

34.64

25.12

16.65

21.10

29.14
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Comparision of Mean Tumor sizes with age groups
60
Whites

African Americans

Others

Mean Tumor sizes

50
40
30
20
10
0
20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+
Age Groups

Figure 2.11 Race wise comparison of mean tumor sizes

2.7 Conclusion
The PDF for all the three races is identified as Inverse Gaussian and the details about
mean tumor sizes along with 95% and 99% confidence intervals for mean tumor sizes for all the
three races were tabulated in Table 2.5. One way ANOVA was performed for comparing mean
tumor sizes of three races and at 5% level of significance, we conclude that the average tumor
size for all the three races is statistically not the same. Later, we performed pair-wise testing
between the races and the results are tabulated in Table 2.6. From these results we conclude that
the average tumor sizes are significantly different for all the three races. Also compared with
Whites and other race women, African American women have comparatively a greater mean
tumor sizes and Whites have the least. This is also supported by the results published in Table
2.7. Finally grouping ages into groups of 5, we also stratified the number of women diagnosed
with breast cancer in different stages and Table 2.8 gives the race wise confidence intervals.
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CHAPTER THREE
Statistical Analysis on Survival times of Breast Cancer Data

3.1 Introduction
Cancer is a major cause of morbidity in the United States, with a total of 1.34 million
cases reported in the year 2005 from 49 of the 50 states (6). Cancer incidence typically rises with
age, and a disproportionate fraction of cases occur among the elderly. According to the statistical
sources, today in the United States, approximately one in eight women over their lifetime have a
risk of developing breast cancer. The statistical methods for survival analysis have been
extracted from the biomedical and epidemiologic studies of humans and animals. Basically,
survival analysis has its application in data evaluation on the length of time it takes for
occurrence of a specific event of interest. The event of interest can be death of person or an
animal or any living being or study of termination of particular equipment. One can identify the
survival rate with a possibility of data collection related to a particular disease. From the recent
data the survival rate of patient with breast cancer is 88% after 5 years of diagnosis and 80%
after 10 years of diagnosis (27).
In his book ‘Natural and Political Observations upon the Bill of Mortality’, John Graunt's
classified registered deaths by age, period, gender and cause of death, suggested for the first time
that death be regarded as an event which deserves systematic study (28,29). Survival data is
mainly concerned with time or study analysis of subject or event of interest. This data may also
contain subjects which have not experienced its effect over a time or complete study of
25

analyticity. For instance, some patients may still be alive at the end of a study period. For these
subjects, the exact survival times are unknown. This scenario can also be exhibited when the
individuals do not follow-up after certain medical attention after a period of study. This would be
beyond the practical limits to wait until every subject has died before conducting any analysis
which is an intrinsic characteristic of survival data. This pattern of behavior cannot be validated
to military and defense officers. Their survival time is usually estimated as the length of survival
time at the time of leaving service and becoming the reserve. The officers that are still active at
end of the study period are treated as censored observations. Further studies like data collection,
evaluation and results related to objective are discussed in following sections.
3.2 Questions of Interest
Q1: Is there a significant difference in the average survival time between the three races?
Q2: Is there a significant difference in the average survival of any two races?
Q3: What is the appropriate probability distribution function (PDF) that best characterizes the
survival time of subjects under study for Whites and African Americans and other races?
Q4: What is the behavior of survival functions for all the three races?
Q5: What are hazard and cumulative hazard curves explaining the behavior of the variable of
interest?
3.3 Data Description
The information that we have used in this present study is obtained from SEER database
registry. This data source SEER (Surveillance Epidemiology and End Results), which is a
unique, reliable and essential resource for investigating the different aspects of cancer. The
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SEER database combines patient-level information on cancer site, tumor pathology, stage, and
cause of death (15, 16). In this work, we preprocessed the SEER data (period of 1992-2008 with
all records named in breast.txt) for breast cancer to remove redundancies and missing
information. The resulting data set provide 47,167 records, which then pre-classified into two
groups of “survived” (29,314; 62.15%) and “not survived” (17,853; 37.85%). The “survived”
class is all records that have a duration period value greater than or equal 204 months and the
“not survived” class represent the remaining records. In all these cases of breast cancer women
analyzed, which included 79.17% White women, 8.98% African American (AA), and 11.86%
other races women (American Indian/AK native, Asian/ Pacific Islander). Our primary variable
of interest here is the survival time and its probabilistic behavior. The overall description is
provided in Table 3.1 and Figure 3.1 provides with the race wise descriptive statistics of the
survival time. Table 3.3 and Table 3.4 have the details about race wise and treatment wise
survival or otherwise of women considered in our data.
Table 3.1 Descriptive Statistics of survival time in months

Race
Whites
AA
Others

Sample Size
37341
4234
5592

Range
202
202
202

Mean
100.05
89.183
101.5

Variance
2512.7
2742.1
2201.5

Median
98
84
97

Table 3.2 Survival based classification

Censor
0 (Dead)
1 (Censored)

Frequency
17853
29314

Percent
37.85
62.15
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Cumulative %
37.85%
100.00%

C.V
0.50102
0.58717
0.46225

Table 3.3 Race wise survival classification

Race

Coded

Whites (W)

1

African
Americans (AA)

2

Others (Oth)

3

Frequency
Percent
Frequency
Percent
Frequency
Percent

Censor = 0
14229
38.1
1992
47.0
1632
29.2

Censor = 1
23112
61.9
2242
53.0
3960
70.8

Total
37341
100
4234
100
5592
100

Figure 3.1 Race wise survival classification

Table 3.4 Treatment Classification

Treatment

Coded

No treatment

1

Radiation

2

Radiation &
Surgery
Surgery

3

4

Censor = 0

Censor = 1

Total

Frequency

6053

14656

20709

Percent

29.2

70.8

100

Frequency

11116

14489

25605

Percent

43.4

56.6

100

Frequency

182

33

215

Percent

84.7

15.3

100

Frequency

502

136

638

Percent

78.7

21.3

100
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Treatment based survival classification
60

54.29
43.91

50
40
30
20
10

0.46

0

1.35

1

2

3
1

2

3

4
4

Figure 3.2 Treatment based survival classification

3.4 Comparing Survival times
Kaplan Meier (KM) curve (30, 31) or the product-limit survival plot indicates the
unconditional probability that a subject will survive beyond time t but do not indicate the
proportion of subjects surviving to time t. Since all observations are considered alive at
beginning of study, the KM survivor function starts at 1 and declines as subjects fail over time.
From the Figure 3.3, we can see that the survival probability of an observation lasting beyond
time period 100 months is about 0.7 for White race women, 0.58 for African American women
and 0.78 for other race women. And the survival probability of a women with breast cancer
surviving beyond time 150 months is about 0.56 for White women, 0.48 for African women and
0.64 for other race women.
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Figure 3.3 Product-Limit survival probability of the three races

Table 3.5 Race Wise Summary Statistics for duration

Summary of the Number of Censored and Uncensored Data
Values
Censored
Stratum RACE Total Censored
Failed
(%)
1
W
37341
23112
14229
38.11
2
AA
4234
2242
1992
47.05
3
Others 5592
3960
1632
29.18
Total
47167
29314
17853
37.85
Table 3.6 Test of equality between three races

Test of Equality over Strata
Test

Chi-Square

DF

Log-Rank

346.8230

2

𝑷𝒓 >
ChiSquare
<.0001

Wilcoxon

403.2763

2

<.0001

-2Log(LR)

332.1676

2

<.0001
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Results of the comparison of survival curves between the three races are shown in Figure
3.2, Table 3.5 and Table 3.6. Table 3.5 has details about race wise censored data followed by test
of equality over the three races in Table 3.6. From Table 3.5, there were a total of 17853 women
(38%) who died of breast cancer. There were a total of 29314 women (62%) that were alive at
the last assessment period. Also, the log-rank test, which places more weight on larger survival
times, is more significant than the Wilcoxon test, which places more weight on early survival
times. Clearly, the rank tests for homogeneity in Table 3.6 indicate a significant difference
between survival times between all the three the races (p < 0.0001 for the log-rank test and p <
0.0001 for the Wilcoxon test). From Figure 3.3, other race women live significantly longer than
White and African American race women, while African American women comparatively have
less survival.

6
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Figure 3.4 Negative Log Survival DF
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Figure 3.5 Log Negative Log vs. Log Duration Survival DF

A plot of the estimated survivor function against time, a plot of the negative log of the
estimated survivor function against time, and a plot of the log of the negative log of the estimated
survivor function against log time are given in Figure 3.3, Figure 3.4, and Figure 3.5
respectively. Figure 3.4 and Figure 3.5 provide an empirical check of the appropriateness of the
exponential model and the Weibull model, respectively, for the survival data.
If the exponential model is appropriate, the curve in Figure 3.4 should be approximately
linear through the origin. Clearly from Figure 3.4 we cannot proceed with exponential model. If
the Weibull model is appropriate, the curve in Figure 3.5 should be approximately linear. From
Figure 3.5, we can notice a non-linear trend in the data, which stops us to proceed even with
Weibull model. Since there is more than one stratum, the Figure 3.5 plot may also be used to
check the proportional hazards model assumption. Under this assumption, the log of the negative
log of the estimated survivor function curves should be approximately parallel across strata,
which in this case fails.
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3.5

Parametric Analysis
Probability theory defines distribution by histogram of survival times, given by

probability density function (PDF) f (t), cumulative distribution function (CDF) which is the
𝑡

cumulative area under histogram starting from left, given by 𝐹(𝑡) = ∫−∞ 𝑓(𝑥)𝑑𝑥, survivor
function 𝑆(𝑡) = 1 − 𝐹(𝑡 ), hazard function ℎ(𝑡) =

𝑓(𝑡)
𝑆(𝑡)

and cumulative hazard function 𝐻(𝑡) =

𝑡

∫0 ℎ(𝑥)𝑑𝑥.
3.5.1

Probability Density Function

The probability density function (PDF) is also very useful in describing the continuous
probability distribution of a random variable. The PDF of a random variable T, denoted𝑓(𝑡), is
defined by𝑓(𝑡) = 𝑑 𝐹(𝑡) / 𝑑𝑡, where 𝐹(𝑡) is the cumulative density function (CDF).That is, the
pdf is the derivative or slope of the cumulative density function (CDF),𝐹 (𝑡). Every continuous
random variable has its own density function, the probability 𝑃 (𝑎 < 𝑇 < 𝑏) is the area under
the curve between a, b. In this chapter we tried to identify the best fit probability function that
characterizes the survival time for all the three races (Whites, AA & Others) separately. We have
identified Generalized Extreme Value distribution (GEV) as the best fit for both White and
African American races with -0.25296, 81.455, 49.931 and -0.17371, 67.907, 49.663 as
estimated shape, location and scale parameters for Whites and African American women
respectively. Lognormal is identified as the best fit for the other race women with estimated
shape, location and scale parameters as 0.07439, -529.26, and 6.4442. Figure 3.6, Figure 3.7,
Figure 3.8 are the PDF’s for the three races and Table 3.7 gives the details of the parameter
estimates of the fit.
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The Generalized Extreme Value (GEV) distribution (32 – 34) is a flexible threeparameter model that combines the Gumbel, Fréchet, and Weibull maximum extreme value
distributions. GEV also has a link to logit functions. GEV has the following analytic form of
PDF,

f (x) =

1
exp{−(1 + 𝑘𝑧)−1⁄𝑘 (1 + 𝑘𝑧)−1−(1⁄𝑘)
𝜎

𝑓𝑜𝑟 𝑘 ≠ 0

1
exp(−𝑧 − exp(−𝑧))
𝜎

𝑓𝑜𝑟 𝑘 = 0

k, σ, µ are the shape, scale, and location parameters respectively. The scale must be positive
(σ >0), the shape and location can take on any real value. The range of definition of the GEV
distribution depends on𝑘. Specifically, the three cases 𝑘 = 0, 𝑘 > 0, 𝑎𝑛𝑑 𝑘 < 0 correspond to
the Gumbel, Fréchet, and "reversed" Weibull distributions.
The three parameter lognormal distribution (34, 35) is based on the Normal distribution. A
random variable is log normally distributed if the logarithm of the random variable is normally
distributed. With 𝑥 > µ ≥ 0 ; −∞ < 𝜎 < ∞; 𝑘 > 0, and µ is the location parameter, that
defines the point where the support set of the distribution begins; σ is the scale parameter that
stretch or shrink the distribution and k is the shape parameter that affects the shape of the
distribution the probability distribution function of three parameter lognormal distribution
function and its corresponding cumulative distribution function (CDF) are given by:
[ln(𝑥 − 𝜇) − 𝜎]2
𝑓(𝑥) =
𝑒𝑥𝑝 {−
}
2𝑘 2
(𝑥 − 𝜇)𝑘√2𝜋
1
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𝐹(𝑥) = Φ {

ln(𝑥 − 𝜇) − 𝜎
}
𝑘

FOR WHITE RACE WOMEN: The fitted GEV distribution that characterizes the breast
1

cancer survival time for White race women is (𝑥) = 49.931 exp{−(1 +
(−0.253)𝑧)−1⁄(−0.253) (1 + (−0.253)𝑧)−1−(−0.253) }; 𝑤ℎ𝑒𝑟𝑒 𝑧 =

𝑥−81.455
49.931

. The graph of the

fitted distribution is given in Figure 3.6.

Figure 3.6 PDF of White (GEV distribution)

FOR AA RACE WOMEN: The fitted GEV distribution that characterizes the breast
1

cancer survival time for AA race women is 𝑓(𝑥) = 49.663 exp{−(1 +
(−0.174)𝑧)−1⁄(−0.174) (1 + (−0.174)𝑧)−1−(−0.174) }; 𝑤ℎ𝑒𝑟𝑒 𝑧 =
fitted distribution is given in Figure 3.7.
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𝑥−67.907
49.663

. The graph of the

Figure 3.7 PDF of AA race (GEV distribution)

FOR OTHER RACES WOMEN: The fitted lognormal distribution that characterizes the
breast cancer survival time for other race women is
𝑓(𝑥) =

1

𝑒𝑥𝑝 {−
(0.0744)(𝑥−(−529.26))√2𝜋

[ln(𝑥−(−529.26))−6.444]2
2(0.0744)2

}.

The PDF graph is given in Figure 3.8.

Figure 3.8 PDF for Other races ( Lognormal distribution)
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Table 3.7 Parameter estimates for the identified distributions

Race

PDF

̂)
Shape(𝒌

Location(𝝁
̂)

Scale(𝝈
̂)

Whites

Generalized Extreme Value

-0.25296

81.455

49.931

African Americans

Generalized Extreme Value

-0.17371

67.907

49.663

Others

Log Normal

0.07439

-529.26

6.4442

3.5.2

Comparison of average survival and confidence interval estimation

The 95% confidence intervals for the mean duration and median survival for all the three
race women are given below in Table 3.8.The median death time (median survival) for a White
women with breast cancer is 179 months and for African American Women is 135 months.
There is no median value reported for the survival of other race women because the product-limit
estimator for these data never reached a failure probability greater than 42.40% or a survival
probability lower than 57.60%. Now we proceed to identify the survival, hazard, cumulative
hazard functions for the three races.
Let 𝜇𝑤 , 𝜇𝑎𝑎 , 𝑎𝑛𝑑 𝜇𝑜𝑡ℎ represent mean survival times of whites, African Americans and
other races respectively. Our interest is to test the hypothesis whether all the three races have
same mean survival time or otherwise.
𝐻0 : 𝜇𝑤 = 𝜇𝑎𝑎 = 𝜇𝑜𝑡ℎ 𝑣𝑠. 𝐻1 : 𝐴𝑡 𝑙𝑒𝑎𝑠𝑡 𝑜𝑛𝑒 𝑜𝑓 𝑡ℎ𝑒𝑚 𝑖𝑠 𝑛𝑜𝑡 𝑒𝑞𝑢𝑎𝑙.
By performing a one way analysis of variance at 5% level of significance, we obtained
the p-value which is very low (p < 0.0001 for F=96.413); leading us to the conclusion that there
is significant difference between the average mean survival times of the three races. Also, nonparametric testing using Kruskal-Wallis supports the current decision. So, we now proceed in
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pair wise testing of mean survival times for all three races. The Table 3.9 below has the details of
the results after performing t-test for pair wise testing. Clearly, we conclude that the average
survival times is significantly different for all the three races in this study. Additionally, at 5%
level of significance, we conclude that average survival times of White women is greater than
African American women and less than other race women. African American women has less
average survival compared to the other two races.

Table 3.8 Confidence intervals of mean duration and median survival

Race

Mean Survival: (95% CI)

Median survival: (95% CI)

Whites

100.05: (99.54, 100.56)

179: (175, 186)

African Americans

89.183: (87.61, 90.76)

135: (126, 145)

Others

101.5: (100.27, 102.73)

-

Table 3.9 Pair-wise hypothesis testing for average survival times of three races

3.6

HNull

HAlternative

𝜇𝑤 = 𝜇𝑎𝑎

𝜇𝑤 not equals 𝜇𝑎𝑎

Pvalue
0.000

Reject Null

95% CI for mean
differences
(9.28, 12.45)

𝜇𝑎𝑎 = 𝜇𝑜𝑡ℎ

𝜇𝑎𝑎 not equals 𝜇𝑜𝑡ℎ

0.000

Reject Null

(-14.32, -10.33)

𝜇𝑤 = 𝜇𝑜𝑡ℎ

𝜇𝑤 not equals 𝜇𝑜𝑡ℎ

0.042

Reject Null

(-2.86, -0.05)

Conclusion

Cumulative Distributive Function
The cumulative distribution function is very useful in describing the continuous

probability distribution of a random variable, such as time, in survival analysis. The cumulative
distribution function (CDF) of a random variable T, denoted 𝐹𝑇 (𝑡), is defined by 𝐹𝑇 (𝑡) =
𝑃𝑇 (𝑇 < 𝑡). This is interpreted as a function that will give the probability that the variable T will
be less than or equal to any value 𝑡 that we choose. Several properties ofa distribution function
𝐹(𝑡) can be listed as a consequence of the knowledge of probabilities. Because 𝐹(𝑡) has the
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probability0 < 𝐹(𝑡) < 1, then 𝐹(𝑡) is a non-decreasing function of t, and as t approaches ∞,
𝐹(𝑡) approaches 1. Figure 3.9, Figure 3.10, Figure 3.11 depict the respective CDF’s for all the

three races.

Figure 3.9 CDF for Whites

The fitted GEV CDF for the other White women is given below. The CDF graph is given
in Figure 3.9.
𝑥 − 81.455
𝐹(𝑥) = 𝑒𝑥𝑝 {− [1 + (−0.253)(
)]
49.931

−1⁄
(−0.253)

}

In the Figure 3.9 above we can clearly notice that for White women with breast cancer
the probability of surviving more than 100 months is little more than 50%. i.e. 𝑃(X 𝑤 > 100) =
0.5. Thus, by 100 months, a White women identified with breast cancer has accumulated quite a
bit of risk, which begins to accumulate more slowly after this point.

39

Similarly, from the Figure 3.10 below we can see that the probability of surviving 100
months or fewer is near 60%. i.e., 𝑃(X𝑎𝑎 > 100) = 0.4. Thus, by 100 months, an African
American women identified with breast cancer has accumulated quite a bit of risk, comparatively
more than White women, which then begins to accumulate more slowly after this point.

Figure 3.10 CDF for African Americans

The fitted GEV CDF for the other AA women is given below. The CDF graph is given in
Figure 3.10.
𝑥 − 67.907
𝐹(𝑥) = 𝑒𝑥𝑝 {− [1 + (−0.174)(
)]
49.663
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−1⁄
(−0.174)

}

Figure 3.11 CDF for Others

The fitted Lognormal CDF for the other race women is given below. The graph of the
same is given in Figure 3.11.

𝐹(𝑥) = Φ {

ln(𝑥 − (−529.26)) − 6.4442
}
0.0744

From the above Figure 3.11 the probability of surviving 100 months or fewer for other
race women is near 50%. i.e., 𝑃(X𝑜𝑡ℎ > 100) = 0.5. Thus, by 100 months, equaling with White
women survival, a patient from other races identified with breast cancer has accumulated quite a
bit of risk by then.

3.7

Survival Function
Let T > 0 have a probability density function (PDF) 𝑓(𝑡)and cumulative distribution

function (CDF)𝐹(𝑡). Survival experience is described by the cumulative survival function given
by
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Survivor function 𝑆(𝑡) = chance of surviving to age t
= percent still alive at age t
𝑆(𝑡) = 𝑃 {𝑇 > 𝑡} = 1 − 𝐹(𝑡)
Evidently, 𝑆(𝑡)is the survival probability: the probability that the event will not happen
until time t. The survival function gives the probability of surviving or being event-free beyond
time t. Because 𝑆(𝑡) is a probability, it is positive and ranges from 0 to 1. It is defined as 𝑆(0) =
1 and as t approaches ∞, 𝑆(𝑡) approaches 0. The Kaplan-Meier estimator, or product limit

estimator, is the estimator used by most software packages because of the simplistic step idea.
The Kaplan-Meier estimator incorporates information from all of the observations available, both
censored and uncensored, by considering any point in time as a series of steps defined by the
observed survival and censored times. The survival curve describes the relationship between the
probability of survival and time.
From the Figure 3.12, the probability of White women surviving beyond 150 months is a
little less than 0.2, and we see that the probability of surviving 150 months or fewer is a little
more than 0.8. From the Figure 3.13 and Figure 3.14, we notice that, the probability of African
American women and other race women surviving beyond 150 months is a little less than 0.1
and 0.15 respectively. Clearly White women has more probability of survival than other two
races. The fitted form of survival functions for all the three races are given below.
For white women: 𝑆(𝑥) = 1 − 𝐹(𝑥) = 1 − 𝑒𝑥𝑝 {− [1 + (−0.253)(

For AA women: 𝑆(𝑥) = 1 − 𝐹(𝑥) = 1 − 𝑒𝑥𝑝 {− [1 + (−0.174)(
For Other race women: 𝑆(𝑥) = 1 − 𝐹(𝑥) = 1 − Φ {
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𝑥−81.455
49.931

𝑥−67.907
49.663

ln(𝑥−(−529.26))−6.4442
0.0744

)]

}

−1⁄
(−0.253)

−1⁄
(−0.174)

)]

}

}

Figure 3.12 Survival DF for Whites

Figure 3.13 Survival DF for African Americans
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Figure 3.14 Survival DF for others

3.8

Hazard Function
The hazard at time t, ℎ(𝑡) as the probability of an event at the interval [𝑡, 𝑡 + 𝛥𝑡],

when𝛥𝑡 → 0. To find an expression for ℎ(𝑡), we should realize that ℎ(𝑡) must be a conditional
probability: it is conditional on not having the event up to time t (or conditional on surviving to
time t.). The hazard is the probability of dying (or experiencing the event in question) given that
patients have survived up to a given point in time, or the risk for death at that moment.
The connection between hazard, survival, PDF and CDF is given below. The CDF is the
best starting point. From CDF we get to PDF and then to hazard. Hazard function,
ℎ(𝑡) = age-specific death rate = percent dying at age t of those alive at age greater or equal to t,
𝑑𝐹⁄
𝑑𝑡 = 𝐹′(𝑡) = 𝑓(𝑡)
ℎ(𝑡) =
𝑆(𝑡)
𝑆(𝑡) 𝑆(𝑡)
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The hazard function has formulation as in the Cox model assumes the subject i at time t
of the form, ℎ𝑖 (𝑡) = ℎ0 (𝑡) 𝑒𝑥𝑝(𝑋𝑖 𝛽 𝑃𝐻 ), where Xi is the set of covariates for subject i (at time t),

βPH is the vector of fixed effects regression coefficients, ho (t) is the baseline hazard (at time t ).
The meaning of the formula stated above implies that if you survive to 𝑡, you will succumb to the
event in the next instant. This function additionally assumes baseline h0 to correspond to specific
distribution with PH property. The above equation is the number of deaths per unit time in the
interval divided by the average number of survivors at the midpoint of the interval. The hazard
function is commonly known as the instantaneous failure rate. It is the measure of the risk of
failure at a point in the time during the aging process.

The graph of the hazard rates of White women (Figure 3.15) shows that probability of
failing (conditional on having survived to time t) remains below 0.05 for the first 100 months
whereas from Figure 3.16 for African American Women probability of failing remains below
0.02 for the first 100 months and hazard rises steeply over 100 months. The hazard of other race
women from Figure 3.17 displays the probability of failing is below 0.016 until first 100 months
and then rising linearly thereafter. The fitted hazard function for all the three races are given
below.
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Figure 3.15 Hazard Function for Whites

ℎ(𝑥) =

1
exp{−(1 +
49.931

(−0.253)𝑧)−1⁄(−0.253) (1 + (−0.253)𝑧)−1−(−0.253) }
𝑥−81.455
)]
49.931

1 − 𝑒𝑥𝑝 {− [1 + (−0.253)(

−1⁄
(−0.253)

}

Figure 3.16 Hazard Function for African Americans

ℎ(𝑥) =

1
exp{−(1 +
49.663

(−0.174)𝑧)−1⁄(−0.174) (1 + (−0.174)𝑧)−1−(−0.174) }
−1⁄
𝑥−67.907
(−0.174)
)]
}
49.663

1 − 𝑒𝑥𝑝 {− [1 + (−0.174)(
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Figure 3.17 Hazard Function for Others

ℎ(𝑥) =

3.9

[ln(𝑥−(−529.26))−6.444]2
1
𝑒𝑥𝑝 {−
}
(0.0744)(𝑥−(−529.26))√2𝜋
2(0.0744)2
ln(𝑥−(−529.26))−6.4442
1 −Φ{
}
0.0744

Cumulative Hazard Function
The cumulative hazard function 𝐻(𝑡)is the integral of the hazard function ℎ(𝑡). It can be

interpreted as the probability of failure at time x given survival until time x. As the name implies,
cumulative hazard function cumulates hazards over time.
𝑡

𝐻(𝑡) = ∫ ℎ(𝑥)𝑑𝑥
0

Clearly is the area under the curve of the function ℎ(𝑥), on the interval from 0 to t. A
given cumulative hazard will remove a certain proportion of objects (or be associated with a
probability of surviving beyond t). For example, a cumulative hazard of 0 (i.e.,𝐻(𝑡) = 0) has
100% associated survival (i.e.𝑆(𝑡) = 1). The above equation can also be expressed as 𝐻(𝑡) =
−ln(1 − 𝐹(𝑡)). The cumulative hazard function gives the number of expected number of failures
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over time interval t. When the survival function is at its maximum at the beginning of analysis
time, the cumulative hazard function is at its minimum. As time progresses, the survival function
proceeds towards it minimum, while the cumulative hazard function proceeds to its maximum.
From Figure 3.18, Figure 3.19 and Figure 3.20 it is clear that the cumulative hazard
function, H (t) increases more rapidly over time, supporting our previous results. H (t) for
African Americans is comparatively more than the other two races.

Figure 3.18 Cumulative Hazard Function for Whites

Figure 3.19 Cumulative Hazard Function for African Americans
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Figure 3.20 Cumulative Hazard Function for others

3.10 Conclusion
Lower p-values in log-rank test and product-limit survival curves indicated a statistically
significant difference between the survival times of all the three races. Compared with White
women and African American women, other race women has more probability of survival. This
is also supported by survival curves and hazard functions in the later sections of this chapter.
However the median survival for other race women and White women is almost same and
African American women has comparatively very less median survival.
Survival resulting from breast cancer specifically were analyzed for the study population
overall by race and treatment taken at diagnosis and summarized in Table 3.3 and Table 3.4.
From Table 3.4, it is interesting to learn that the probability of survival and death is almost very
close for the patients who underwent radiation alone. The probability density function that best
characterizes the behavior of survival time are identified as GEV distribution for Whites and
African American race women and Log Normal distribution for other race women. The
parameter estimates of these distributions are given in Table 3.7.
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CHAPTER FOUR
Modeling of Breast Cancer Survival Data

4.0 Introduction
Survival analysis today is widely implemented in the fields of medical and biological
sciences, social sciences, econometrics, and engineering. The basic principle behind the survival
analysis implies to a statistical approach designed to take into account the amount of time
utilized for a study period, or the study of time between entry into observation and a subsequent
event. The event of interest pertains to death and the analysis consisted of following the subject
until death (36). Events or outcomes are defined by a transition from one discrete state to another
at an instantaneous moment in time. Examples include time until onset of disease, time until
stock market crash, time until equipment failure, and so on. Although the origin of survival
analysis rests with the mortality tables from centuries ago, this type of analysis was not well
developed until World War II (37). At the end of the war, the use of these newly developed
statistical methods quickly spread through private industry as customers are demanding for safer
and more reliable products.
In survival analysis, a data set can be categorized as exact or censored, and it may also be
truncated. Another name for exact data is uncensored data which occurs only when the precise
time until the event of interest is known. Censored data arises when a subject’s time until the
event of interest is known to occur only in a certain period of time. For example, if an individual
drops out of a clinical trial before the event of interest has occurred, then that individual’s time50

to-event is right censored at the time point at which the individual left the trial. The time until an
event of interest is truncated if the event time occurs within a period of time that is outside the
observed time period (38).
4.1 Questions of Interest
Q1: How long a woman with breast cancer will survive after undergoing certain
treatments? (Radiation or surgery or both radiation and surgery or no treatment).
Q2: What is the effectiveness of treatments when implemented in different stages of
breast cancer?
Q3: Given a vector of covariates or explanatory variables is there a parametric survival
model that may affect survival time of breast cancer women?
Q4: How good is the popular Kaplan Meier survival analysis when compared with others
(parametric and nonparametric functions)?
Q5: Does the Cox proportional hazards survival analysis provide any additional
information with respect to survival function?
Q6: Is there any significant difference in proposed parametric survival model and Cox
PH models?

4.2 Survival and Hazard functions
Survival time can be estimated as a variable which calculates the time between the
starting point and ending point of event of interest or time of interest. In medical field (39) it is
termed as the period elapsing between the completion or institution of any procedure and death.
The survival time and event data is collected on practical grounds which is either censored or
truncated.
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Let us recall the definition of survival function as discussed in the previous chapter. This
survival function is also termed as survivor or reliability function. It is defined as the probability
associated with the mortality rate or failure of some system. This survival function (40) is
obtained by plotting graph of associated probabilities against time. The survival function can be
expressed with help of another distribution used commonly in statistical techniques, namely
cumulative probability function CDF denoted as F(t). The survivor function is defined as the
complement of the CDF which is formulated in the relationship below
𝑆(𝑡) = 𝑃𝑟(𝑇 > 𝑡) = 1 − 𝐹(𝑡)
Similarly Hazard function is an alternative representation of the distribution of T or the
instantaneous occurrence of the event and is defined as
Pr(𝑡 < 𝑇 ≤ 𝑡 + 𝑑𝑡|𝑇 > 𝑡)
𝑑𝑡→0
𝑑𝑡

𝜆(𝑡) = lim

The above expression is termed as the instantaneous rate of occurrence for the
conditional probability that the event will occur in the time interval between t and (t+dt) as it has
not occurred before.
By the prior computation of the conditional probability in the numerator and application
of limits gives the hazard function as
𝜆(𝑡) =

𝑓(𝑡)
𝑆(𝑡)

In other words the hazard function can be stated as the rate of the occurrence of the event
at time 𝑡 equals to the probability density at time 𝑡 divided over the probability of the surviving
to that duration without experiencing the event. The above formula can be expressed using the
relation between density and survival function as follows
𝑑
log 𝑆(𝑡)
𝑑𝑡
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𝜆(𝑡) = −

The above expression of hazard function is integrated using limits 0 to 𝑡 and applying the
boundary condition S(0)=1 (which implies event not occurred at time 0) to obtain relation
between hazard and survival function as follows
𝑡

𝑆(𝑡) = exp(− ∫ 𝜆(𝑥)𝑑𝑥)
0

4.3 Statistical Approach of Survival Analysis
The survival analysis can be carried out using various statistical approaches (41) like
1. Descriptive statistics (includes mean or median of survival, average hazard rate etc.)
2. Univariate statistics (survival curves)
3. Multivariate statistics (Parametric, non-parametric and semi-parametric survival analysis)
The first two classifications of survival analysis have their respective advantages and
disadvantages which are applicable in only few cases. The third classification is observed to be
present generation scenario for survival function analysis. Survival models for the analysis of
data have three main characteristics: (i) the dependent variable or response is the waiting time
until the occurrence of a well-defined event, (ii) observations are censored, in the sense that for
some units the event of interest has not occurred at the time the data are analyzed, and (iii) there
are predictors or explanatory variables whose effect on the waiting time we wish to assess or
control (128).
The basic definition of three types of analysis carried under multivariate statistics are
given below.
1. Parametric Analysis: This analysis assumes distributions for outcome, and base statistical
analysis on assumed distributions (check the validity of assumptions).
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2. Non-parametric Analysis: This analysis avoids distribution or quantitative assumptions and
relies completely on design properties.
3. Semi-parametric Analysis: This analysis is an intermediate between above two types of
analysis, but will make some assumptions to avoid fully specified statistical model (42).
4.4 Non-parametric Analysis (NP)
Estimating the distribution of the dependent variable without making assumptions about
its shape is an important first step in analyzing a dataset. Given the importance of the distribution
of the dependent variable it is valuable to “let the data speak for itself” first (43). Estimating the
probabilities without making any assumptions on its shape is called non-parametric analysis. The
function used to represent the distribution is the Survivor function. Nonparametric methods do
not require the knowledge of the underlying distribution of the failure time 𝑡. Hence it provides
an edible way to deal with the data in many practical situations. The seminar paper by Kaplan
and Meier (44) is the benchmark in survival analysis especially from nonparametric point of
view. It compelled the application of descriptive statistics and improved the development of all
existing NP approaches with censored data. The survivor function is calculated by dividing the
number of survivors by the total number of subjects for every time.
4.4.1 Kaplan-Meier Estimator
The Kaplan-Meier estimator originally was derived as an NP maximum likelihood
estimator of 𝐹(𝑡). Because of the latter method of derivation, it is also called as the product-limit
(PL) estimator. If the data was not censored then the empirical survival function is given by
𝑛

1
𝑆(𝑡) = ∑ 𝐼{𝑡𝑖 > 𝑡},
𝑛
𝑖=1
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Where 𝐼 is termed as the indicator function which takes a value of one if the condition
𝑡𝑖 > 𝑡 is true or zero otherwise (45). The estimator is simply the proportion alive at 𝑡. For the
censored data, assume the ordered times of death as𝑡1 < 𝑡2 < 𝑡3 … … < 𝑡𝑚 and 𝑑𝑘 be the death
occurred at 𝑡𝑘 . Let 𝑛𝑘 be the number of persons alive just before 𝑡𝑘 . This is the number exposed
to risk at that time. The Kaplan-Meier (KM) or product limit estimate of the survivor function is
𝑆̂(𝑡) = ∏ (1 −
𝑖:𝑡(𝑖) <𝑡

𝑑𝑖
)
𝑛𝑖

The justification of the estimate is explained as follows. In order to survive until the time
𝑡 one must first survive until the time 𝑡1 . And the conditional probability of surviving from 𝑡2 to
𝑡1 given already survived 𝑡1 is to be satisfied. The Kaplan-Meier (KM) is a step function with
jumps at the observed times. If no censoring is present, the KM coincides with the empirical
survival function (46).
As mentioned earlier, KM estimator can be interpreted as the non-parametric likelihood
estimator (NPML) for the death or censored data at time 𝑡. The assumptions formulated for this
method requires that the likelihood of the subject is 𝑆(𝑡) at 𝑡 is to be maximized as large as
possible. Since the survival is a non-decreasing function, it does not change at the censoring
times. Also if a person dies at 𝑡 which is distinct from times of the death we introduced before.
Let it be time 𝑡𝑖 . We need to make the survival function before 𝑡𝑖 as large as possible. Based on
the above criteria the likelihood takes the form
𝑚

𝐿𝑖 = ∏[𝑠(𝑡(𝑖−1) ) − 𝑆(𝑡(𝑖) )]𝑑𝑖 𝑆(𝑡(𝑖) )𝑐𝑖
𝑖=1
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This is the product over 𝑚 distinct times of death. By taking 𝑡(0) = 0 with 𝑆(𝑡(0)) = 1.
Estimation of survival function at the death times 𝑡(1), 𝑡(2), . . . , 𝑡(𝑚) for 𝑚 parameters is
obtained.
𝜋𝑖 =

𝑆(𝑡𝑖 )
𝑆(𝑡𝑖−1 )

Writing the above expression for the conditional probability of surviving from 𝑆(𝑡𝑖−1 ) to
𝑆(𝑡𝑖 ). Then we can write 𝑆(𝑡𝑖 ) = 𝜋1 𝜋2 … … … 𝜋𝑖 , and the likelihood changes to the following
expression
𝑚
𝑐

𝐿𝑖 = ∏(1 − 𝜋𝑖 )𝑑𝑖 𝜋𝑖 𝑖 (𝜋𝑖 𝜋2 … … . . 𝜋𝑖−1 )𝑑𝑖 +𝑐𝑖
𝑖=1

In all these cases, individuals who die at time 𝑡𝑖 or the time between 𝑡𝑖 and 𝑡𝑖+1 also
contribute to the term 𝜋𝑗 to each of the previous term of death from 𝑡(1) to 𝑡(𝑖−1) . Let us assume
𝑛𝑖 = ∑𝑗≥𝑖(𝑑𝑗 + 𝑐𝑗 ) to be number exposed to risk at 𝑡𝑖 and now the L likelihood can be written as
𝑚

𝐿𝑖 = ∏(1 − 𝜋𝑖 )𝑑𝑖 𝜋𝑖 𝑛𝑖 −𝑑𝑖
𝑖=1

The maximum likelihood estimator of 𝜋𝑖 is then
𝑆̂(𝑡) = 𝜋̂𝑖 =

𝑛𝑖 − 𝑑𝑖
𝑑𝑖
=1− .
𝑛𝑖
𝑛𝑖

In order to estimate 𝑣𝑎𝑟 (𝑆̂(𝑡)), we use the delta method which says, if X ~𝑁(𝜇, 𝜎 2 ) then
𝑓(𝑋) is approximately normally distributed with mean 𝑓(𝜇) and variance [𝑓 ′ (𝜇)]2 𝜎 2 . Also
instead of estimating the 𝑣𝑎𝑟 (𝑆̂(𝑡)), we can use the delta method to approximate the
𝑣𝑎𝑟(log (𝑆̂(𝑡)) with log (𝑆̂(𝑡))=∑𝑗:𝑡𝑗 <𝑡 log(1 − 𝜆̂𝑗 ). Using independence of the 𝜆̂𝑗 ′𝑠 we get the
Greenwood’s Formula given by
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2

𝑣𝑎𝑟 (𝑆̂(𝑡)) = [𝑆̂(𝑡)] 𝑣𝑎𝑟 [log (𝑆̂(𝑡))],

Implying,
𝑑𝑗

2

𝑣𝑎𝑟 (𝑆̂(𝑡)) = [𝑆̂(𝑡)] ∑
𝑗:𝑡𝑗 <𝑡

(𝑟𝑗 − 𝑑𝑗 )𝑟𝑗

And the sample standard error for computing confidence interval is given by

𝑆𝐸 (𝑆̂(𝑡)) = 𝑆̂(𝑡)√ ∑
𝑗:𝑡𝑗 <𝑡

𝑑𝑗
(𝑟𝑗 − 𝑑𝑗 )𝑟𝑗

4.4.2 The Nelson-Aalen Estimator
For estimating a cumulative hazard 𝐻(𝑡), one simple approach is to find an estimator of 𝑆(𝑡)
and take minus the log. An alternativeapproach is to estimate the cumulative hazard directly
using the Nelson-Aalen estimator. The Nelson Aalen estimator is a non-parametric estimator of
the cumulative hazard rate function from censored survival data (47). Consider a sample of n
individuals from a right censored survival population. Our observation of the survival times for
these individuals will typically be subject to right censoring meaning that for some individuals
we only know that their true survival times exceed certain censoring times. The censoring is
assumed to be independent in the sense that the additional knowledge of censorings before any
time t does not alter the risk of failure at t. The Nelson-Aalen estimator is a step function with the
location of the steps placed at each observed death time and the vertical size of the steps is the
inverse of number at risk, Where number at risk is the number of patients just before the death
that are still observed to be alive. With larger samples the Nelson-Aalen estimator will get closer
to the true cumulative hazard. The Nelson-Aalen estimator is given by
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̂=∑
𝐻(𝑡)
𝑡𝑗 <𝑡

𝑑𝑗
𝑟𝑗

where 𝑑𝑗 is the subjects who die at time𝑡𝑗 and 𝑟𝑗 is the number of subjects at risk just prior to time
𝑡𝑗 . The variance of the estimator is given by
̂) = ∑
𝑉𝑎𝑟(𝐻(𝑡)
𝑡𝑗 <𝑡

𝑑𝑗 (𝑟𝑗 − 𝑑𝑗 )
𝑑𝑗
≈∑ 2
2
𝑟𝑗 (𝑟𝑗 − 1)
𝑟𝑗
𝑡𝑗 <𝑡

The advantage of non-parametric analysis is that the results do not rest on the
assumptions. The disadvantage is that we can only compare limited number of groups which
implies it is very difficult to see the impact of multiple explanatory variables on the subjects
(48). Another disadvantage of non-parametric techniques is that it can only deal with the
quantitative explanatory variables like GDP, rich and poor countries etc.
4.4.3 Kaplan Meier Estimation for breast cancer survival
4.4.3.1 Effect of treatments on survival of breast cancer
Considering the breast cancer survival data, in this chapter we are interested in knowing
how long women with breast cancer will survive after undergoing certain treatments. Treatments
include radiation or surgery or both radiation and surgery or no treatment. Also we would like to
know the effectiveness of treatments when implemented in different stages of breast cancer.
Firstly we considered the effectiveness of treatments on survival for the overall data. From the
Table 4.1 women who are treated with radiation have a median survival of 154 months with 95%
CI (149, 157) months. Interestingly, women those who are treated with both treatments has the
same median survival as of women who received surgery. There is no median value reported for
the survival of women who did not receive any treatment because the KM estimator for these
data never reached a failure probability greater than 41.50% or a survival probability lower than
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58.50%. Figure 4.1 is the product-limit survival graph for all the four treatment types.
Treatments 3 & 4 in the graph follow almost the same path. The probability of survival for a
women identified with breast cancer to survive more than 50 months is approximately 82% for
women who did not receive any treatment, 78% for surgery, 30% for combination of radiation
and surgery and 30% for those who are treated with surgery.

Table 4.1 Treatment wise KM estimates for median survival

Treatment

No treatment

Radiation

Median Survival
95% CI

-

154
[149, 157)

Radiation &
Surgery
25
[21, 30)

Figure 4.1 Product-Limit estimates for treatments
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Surgery
25
[21, 29)

Table 4.2 Stage vs. Treatment Product-Limit Estimates for median survival

Stage I

No
treatment
─

Stage II

─

Stage
III
Stage
IV

Radiation
178(172, -)
145(140,
149)

Radiation &
Surgery
104(53, -)

62(42, 100)

128(45, -)

43(32, 66)

Surgery

93(81, 103)

52(47, 57)

32(24, 110)

27(17, 31)

34(28, 39)

23(21, 27)

17.5(12, 22)

14.5(11, 18)

4.4.3.2 Stage wise effect of treatments of breast cancer
Further we continued to check the survival probability of breast cancer women treated in
every stage with different treatments. The median survival in months and the respective 95%
confidence interval based on their stage of cancer is tabulated in Table 4.2. The median survival
for those who are in stage I and stage II who did not receive any treatment for breast cancer is
not reported because the KM estimator for these data never reached a failure probability greater
than 35.28% or a survival probability lower than 64.72% for the former case and data never
reached a failure probability greater than 45.29% or a survival probability lower than 54.71% for
the latter case. The Figure 4.2 clearly depicts that the probability of survival for those who are
treated with surgery in all the four stages falls down rapidly.

60

Stage-2 vs. Treatments

Stage-1 vs. Treatments

Stage-3 vs. Treatments

Stage-4 vs. Treatments

Figure 4.2 KM Estimates for Stages Vs. Treatments
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4.5 Parametric Analysis
This type of analysis assumes a functional form of the probability distribution and the
way in which explanatory variables influence the survival time. The first assumption is also
called as time dependence because of its functional form of probability distribution. With
growing computing power and existing statistical programming languages, it is relatively simple
to work with exact likelihood for censored or truncated data with a variety of parametric models.
Parametric survival model provides the possibility of more efficiency (43). It is proved to be
interesting to assume a specific distribution for underlying hazard function (to obtain a full
hazard or survival function). There may be a provision for non-proportional hazard functions
also. The direct regression approach for the survival time estimation is given by
𝐸(𝑡𝑖 ) = 𝛽𝑜 + 𝑋𝑖 𝛽 or 𝑡𝑖 = 𝛽𝑜 + 𝑋𝑖 𝛽 + 𝜀𝑖
where 𝜀𝑖 refers to the survival error distribution.
This direct regression computation has some problems for estimating survival time like
the distribution of ti is right skewed (non-normal), the estimator of time may not be the parameter
of interest (not equal to hazard) and censoring must be accounted.
The above concerns are addressed using two possible approaches of parametric analysis.
1. Accelerated failure time models (AFT models)
2. Proportional hazard model (PH models) (49)
These models are provided as the common scales for the distributions in parametric
survival models. Both PH and AFT models were analyzed on basis of t-scale over the
distributions with interval (0, ∞), whereas the AFT models were also interpreted on the basis of
𝑙𝑛(𝑡) − scale over the distributions termed as pure AFT models. Distributions that are commonly
used in parametric analysis using AFT are addressed below.
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4.5.1 Parametric Model selection: Goodness of fit Tests
There are few common statistical methods for comparisons of survival models.
a) Log-likelihood test for the censored data,
b) AIC,
c) Cox-Snell Residual plots and
d) Likelihood-Ratio Statistic.
The AIC is an operational way of trading off the complexity of an estimated model
against how well the model fits the data. The AIC is calculated by
𝐴𝐼𝐶 = −2 𝑙𝑜𝑔 (𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑) + 2 (𝑝 + 𝑘),
where 𝑝 is the number of parameters, 𝑘 = 1 for the exponential model, 𝑘 = 2 for the Weibull,
log logistic, and log normal models and 𝑘 = 3 for generalized gamma.
A likelihood ratio test (LRT) is also used to compare the fit of two models. The LRT test
statistic is twice the difference in the log-likelihoods of the models considered for comparison.
We generally select the model that gives the largest log-likelihood.
Other methods include graphical methods (for all distributions mentioned), Cox-Snell
Residual plots among others (52). Parametric models are ﬁt to the event times and semiparametric models are ﬁt to the ordered event times respectively. In both the cases we use the
AIC to select between parametric models, or to select between semi-parametric models, but not
to select from a mixture of the two. The AIC or likelihood tests allow us to assess relative model
goodness of ﬁt, but not absolute model goodness of ﬁt. Just because the second model ﬁts better
than the first model, it does not mean the second model adequately describes the data. Thus, we
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would like a method, at least a graphical one that lets us assess the absolute goodness of ﬁt of a
parametric model. The Table 4.3 below provides information regarding graphical check for
goodness of fit for the identified parametric model for survival data (53, 54).
Table 4.3 Graphical check for goodness of fit for parametric survival models

Graph

Behavior

Resulting Distribution

−𝑙𝑜𝑔𝑆(𝑡) versus 𝑡

Straight line through origin.

Exponential

log[−𝑙𝑜𝑔𝑆(𝑡)] versus log 𝑡

Straight line

Weibull

Φ−1 (1 − 𝑆(𝑡)) versus log 𝑡

Straight line, where Φ( ) is the CDF.

Log-normal

Straight line

Log-logistic

log [

1−𝑆(𝑡)
𝑆(𝑡)

] versus log 𝑡

4.5.2 Parametric modeling of breast cancer data

Our data consists of 47167 breast cancer patients identified with malignant breast tumors.
Patients are either White women, African American women or other race women, stratified into
four stages of cancer and are treated with either radiation or surgery or combination of both or no
treatment. Other covariates include grade of tumors, number of primary tumors, age, and marital
status. For the rest of this chapter the variables and their representations are given in the Table
4.4 below.
It is of substantial interest in performing the parametric modeling is to see the difference
in survival (in months) between those patients undergone with different treatments, after
adjusting for patient’s cancer stage, age, marital status, race, grade of tumor, and the number of
primary tumors. We used SAS software to fit different parametric models. After performing
univariate analysis marital status of woman is not statistically significant and hence is dropped
from modeling.
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When comparing parametric models, the Akaike Information Criterion (AIC) and loglikelihood values (54) can be used to select the best parametric model. The best fit model is the
one with smaller AIC and largest Log-likelihood. Once the model is identified we will perform a
residual analysis check that lets us assess the absolute goodness of ﬁt of the identified parametric
model.
Table 4.4 Variables used in survival modeling

Age

Grade

Numprims

Treatments

Stage
Race
Tumor Size

𝑋1
𝑋2𝑖
i=1:Well differentiated
2:Moderately differentiated
3:Poorly differentiated
4:undifferentiated
9:Cell type not determined
(reference)
𝑋3
𝑋4𝑖
i=1:No Treatment
2:Radiation
3: Radiation & Surgery
4: Surgery (reference)
𝑋5𝑖 ; i=1,2,3,4(reference)
𝑋6𝑖
i=1: Whites
2: African Americans
3: Other races(reference)
𝑋7

4.5.3 Parametric survival model using AFT class
Let 𝑇𝑖 denote a continuous non-negative random variable representing survival time of
the 𝑖 𝑡ℎ unit, the logarithm can be used as conventional modeling which is formulated below
ln(𝑇𝑖 ) = 𝑋𝑖 𝛽 + 𝜎𝜖𝑖 𝑜𝑟 𝑇𝑖 = exp(𝑋𝑖 𝛽) exp(𝜎𝜀𝑖 ) = 𝑇0𝑖 exp(𝑋𝑖 𝛽)
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where 𝜀𝑖 is termed as a suitable error in the ln(t)-scale which is specific for a distribution,
and 𝑇0𝑖 = exp(𝜎𝜀𝑖 ) is the error corresponding to the original (t) scale. The term 𝑇0𝑖 indicate the
baseline function at 𝑖 = 0. This implies that the explanatory variables act in multiples and direct
product on the survival time and their effect is to increase or decrease the time of death with
respect to the baseline function. The baseline function is specified up to an unknown parameter.
The term exp(−𝑋𝑖 𝛽) is termed as the acceleration parameter. This parameter is different from
the value in PH model. From the industrial applications point of view, the name ‘accelerated life’
implies to the testing of the units to substantial worse conditions rather than they actually
encounter in real life. Different kinds of parametric models are obtained assuming different types
of distributions for error term𝜖𝑖 .Accelerated life models are considered as standard regression
models appliedto the natural logarithm of survival time, and except for the fact that observations
are censored, pose no new estimation problems. This model estimates goodness of fit for
different distributions using Likelihood ratio (LRT) or Akaike Information criterion (AIC). Once
the distribution of the error term is chosen, estimation is carried out by maximizing the loglikelihood for censored data (50) which is also termed as a Tobit model in economic literature.

4.5.4 Exponential distribution
In regression models it is common practice that the dependent variable depends on the
explanatory variables only through a linear function. Because of its historical significance,
mathematical simplicity and important properties, the exponential distribution is one of the most
popular parametric models. This is the simplest possible distribution with one parameter which is
derived treating the hazard function as a constant and of monotonic value over baseline hazard
function denoted as ℎ(𝑡) = 𝜆.
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ℎ(𝑡) = exp(𝛽0 ) exp(𝑋𝑖 𝛽)
So for the exponential distribution the instantaneous failure rate is independent of 𝑡 so
that the conditional chance of failure does not depend on how long the individual has been on
trial. This is referred to as the memory less property of the exponential distribution.

4.5.4.1 Fitting Exponential Model
The survival and fitted survival functions for exponential parametric model are given by
equations below. Table 4.5 has the analysis of the maximum likelihood estimation of parameters
of the Exponential model for breast cancer patients.
𝑆(𝑡; 𝑿) = exp(−𝑡[𝑒𝑥𝑝(−𝑏0 − 𝑏1 𝑋1 − 𝑏2 𝑋2 … − 𝑏𝑘 𝑋𝑘 )]) and
𝑆(𝑡; 𝑿) = 𝑒𝑥𝑝{−𝑡{exp(−5.36 + 0.03𝑋1 − 0.32𝑋21 − 0.14𝑋22 + 0.17𝑋23 + 0.21𝑋24 +
0.09𝑋3 − 0.95𝑋41 − 0.63𝑋42 − 0.26𝑋43 − 1.89𝑋51 − 1.46𝑋52 − 0.72𝑋53 + 0.15𝑋61 +
0.40𝑋62 + 0.0004𝑋7 )}}.
Table 4.5 Analysis of MLEs for Exponential Model

Analysis of Maximum Likelihood Parameter Estimates
Parameter

DF Estimate

S. E. 95% Confidence
Limits

Intercept

1

5.3589 0.0831

AGE

1

-0.0321 0.0006

5.1960 5.5219

Pr >
ChiSq
<.0001

-0.0334 -0.0309 <.0001

GRADE

1

1

0.3171 0.0350

0.2485 0.3857

<.0001

GRADE

2

1

0.1368 0.0293

0.0794 0.1943

<.0001

GRADE

3

1

-0.1723 0.0291

-0.2293 -0.1153 <.0001

GRADE

4

1

-0.2108 0.0560

-0.3206 -0.1011 0.0002

GRADE

9

0

0.0000

.

NUMPRIMS

1

-0.0851 0.0135

TREATMENT 1

1

0.9496 0.0509
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. .

.

-0.1116 -0.0586 <.0001
0.8499 1.0494

<.0001

Table 4.6 (Continued) Analysis of MLEs for Exponential Model

Analysis of Maximum Likelihood Parameter Estimates
Parameter

DF Estimate

S. E. 95% Confidence
Limits

Pr >
ChiSq

TREATMENT 2

1

0.6257 0.0499

0.5278 0.7236

<.0001

TREATMENT 3

1

0.2614 0.0869

0.0910 0.4318

0.0026

TREATMENT 4

0

0.0000

STAGE

1

1

1.8855 0.0381

1.8108 1.9602

<.0001

STAGE

2

1

1.4624 0.0373

1.3894 1.5354

<.0001

STAGE

3

1

0.7280 0.0418

0.6462 0.8099

<.0001

STAGE

4

0

0.0000

RACE

1

1

-0.1512 0.0265

-0.2033 -0.0992 <.0001

RACE

2

1

-0.3980 0.0337

-0.4642 -0.3319 <.0001

RACE

3

0

.

.

0.0000

.

. .

.

.

.

. .

. .

TUMOR_SIZE

1

-0.0004 0.0001

-0.0005 -0.0002 <.0001

Scale

0

1.0000 0.0000

1.0000

1.0000

Weibull Shape

0

1.0000 0.0000

1.0000

1.0000

4.5.4.2 Exponential Residual Plot
To evaluate the goodness of fit for exponential model we performed a residual analysis
for observed and fitted data. The result shows that the mean residual is 0.3785, with a standard
deviation of 0.3523 and a range of 12.157. A residual graph of survival functions for exponential
parametric model is shown in Figure 4.3. Clearly the fitted data does not fall close to the straight
line which explains that exponential is not the best fit for this data.
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Figure 4.3 Residual plot for exponential distribution

4.5.5 Weibull distribution
Although the exponential model is good, there is improper assumption that the hazard
function is constant over the time. If the hazard model is increasing or decreasing over the time,
the exponential model will miss this fact under such assumption. The general Weibull model as a
hazard function can be formulated as
ℎ(𝑡) = 𝑝𝜆𝑡 𝑝−1
The parameter p is called as the shape parameter which is one in case of exponential
distribution. For the values of p other than one the hazard function increases or decreases
monotonically. In case of AFT, Weibull model is represented as,
𝑇𝑖 = exp(𝑋𝑖 𝛽) × 𝜎𝜖𝑖
Which implies the shape function is determined by the variance of the residuals.
Intuitively, data with low variance duration dependence will tend to exhibit positive duration
dependence, due to their relative lack of heterogeneity. Furthermore, Weibull in case of hazard
ratio for two observations with different values i and j can be interpreted as follows
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exp(𝑋𝑖 𝛽)
exp(𝑋𝑗 𝛽)

𝐻𝑅 𝑖 =
𝑗

This indicates that the hazard ratio for different cases can only differ by dichotomous
variable which is exp(𝛽).

4.5.5.1 Fitting Weibull Model
The survival and fitted survival functions for Weibull parametric model are given by
equations below. Table 4.6 has the analysis of the maximum likelihood estimation of parameters
of the Weibull model for breast cancer patients.
𝑆(𝑡; 𝑿) = exp(−𝑡 𝑘 𝑒𝑥𝑝(−𝑏0 − 𝑏1 𝑋1 − 𝑏2 𝑋2 … − 𝑏𝑘 𝑋𝑘 )) and
𝑆(𝑡; 𝑿) = 𝑒𝑥𝑝{−𝑡 0.85 {exp(5.22 + 0.03𝑋1 − 0.25𝑋21 − 0.10𝑋22 + 0.20𝑋23 + 0.21𝑋24
+ 0.07𝑋3 − 0.88𝑋41 − 0.59𝑋42 − 0.24𝑋43 − 1.7𝑋51 − 1.32𝑋52 − 0.67𝑋53
+ 0.13𝑋61 + 0.35𝑋62 + 0.0003𝑋7 )}}

4.5.5.2 Weibull Residual Plot
To evaluate the goodness of fit for the Weibull model we performed a residual analysis
for observed and fitted data. The result shows that the mean residual is 0.3785, with a standard
deviation of 0.3887 and a range of 14.633. A residual graph of survival functions for Weibull
parametric model is shown in Figure 4.4. Clearly the fitted data does not fall close to the straight
line which explains that exponential is not the best fit for this data.
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Table 4.7 Analysis of MLEs for Weibull Distribution

Analysis of Maximum Likelihood Parameter Estimates
Parameter

DF Estimate S. E.

95% Confidence
Limits

Intercept

1

5.2216 0.0708 5.0827

AGE

1

-0.0287 0.0006 -0.0297

5.3604

Pr >
ChiSq
<.0001

-0.0276 <.0001

GRADE

1

1

0.2513 0.0298 0.1929

0.3097

<.0001

GRADE

2

1

0.0974 0.0249 0.0486

0.1462

<.0001

GRADE

3

1

-0.1761 0.0247 -0.2245

-0.1277 <.0001

GRADE

4

1

-0.2086 0.0475 -0.3017

-0.1155 <.0001

GRADE

9

0

0.0000

. .

.

.

NUMPRIMS

1

-0.0694 0.0115 -0.0919

TREATMENT 1

1

0.8678 0.0433 0.7829

0.9527

<.0001

TREATMENT 2

1

0.5897 0.0424 0.5065

0.6728

<.0001

TREATMENT 3

1

0.2360 0.0738 0.0914

0.3805

0.0014

TREATMENT 4

0

0.0000

.

.

STAGE

1

1

1.6954 0.0331 1.6305

1.7603

<.0001

STAGE

2

1

1.3236 0.0320 1.2608

1.3863

<.0001

STAGE

3

1

0.6660 0.0355 0.5964

0.7356

<.0001

STAGE

4

0

0.0000

.

.

RACE

1

1

-0.1255 0.0225 -0.1696

-0.0813 <.0001

RACE

2

1

-0.3465 0.0287 -0.4028

-0.2903 <.0001

RACE

3

0

. .

. .

0.0000

. .

-0.0469 <.0001

.

TUMOR_SIZE

1

-0.0003 0.0001 -0.0005

Scale

1

0.8484 0.0055 0.8376

0.8593

Weibull Shape

1

1.1787 0.0077 1.1638

1.1939
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.

-0.0002 <.0001

Figure 4.4 Residual plot for Weibull distribution

4.5.6 Log-normal and Log-Logistic distributions
There are also certain other models which received importance in social sciences. They
can be noted probably as common models which are beyond the exponential and Weibull
models. Both of the models are considered strictly AFT models. Recalling the general equation
of AFT model, ln(𝑇𝑖 ) = 𝑋𝑖 𝛽 + 𝜎𝜖𝑖 .
If the error 𝜖𝑖 in the above equation is assumed to follow a logistic distribution (55) then
the resulting model is termed as the log-logistic survival model. If the model follows a standard
normal distribution, it is termed as log-normal survival model. The standard log-logistic survival
function is equal to
𝑆(𝑡) =

1
1 + (𝜆𝑡)𝑝

and the corresponding hazard function is equal to
ℎ(𝑡) =

𝜆𝑝(𝜆𝑡)𝑝−1
1 + (𝜆𝑡)𝑝
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Similarly the log-normal model is assumed to have bell-shaped symmetrical distribution
(51) for the error term. If we assume errors to be normally distributed then the corresponding
cumulative errors are also normal. The survival function of the log-normal is given by
𝑆(𝑡) = 1 − Φ [

𝑙𝑛𝑇 − ln(𝜆)
]
𝜎

In general, log-logistic and log-normal models are very similar and will produce similar
results like logit and probit models in the regression analysis. Also, log-logistic models with p>1
and log-normal models with all possible values of the p will first rise and then fall over time.

4.5.6.1 Fitting Log-Normal and Log-Logistic distribution
The survival and fitted survival functions for lognormal parametric model are given by
equations below. Table 4.7 has the analysis of the maximum likelihood estimation of parameters
of the lognormal model for breast cancer patients. 𝑆(𝑡) = Φ[𝑏0 + 𝑏1 𝑋1 + 𝑏2 𝑋2 + ⋯ − 𝑘 log(𝑡)];
Here Φ is the cumulative distribution function of standard normal distribution.
𝑆(𝑡) = Φ[4.69 − 0.03𝑋1 + 0.27𝑋21 + 0.12𝑋22 − 0.2𝑋23 − 0.24𝑋24 − 0.82𝑋3 + 1.06𝑋41
+ 0.76𝑋42 + 0.35𝑋43 + 1.96𝑋51 + 1.54𝑋52 + 0.8𝑋53 − 0.13𝑋61 − 0.38𝑋62
− 0.0004𝑋7 − 1.07 log(𝑡)]
The survival and fitted survival functions for log-logistic parametric model are given by
equations below. Table 4.8 has the analysis of the maximum likelihood estimation of parameters
of the log-logistic model for breast cancer patients.
𝑆(𝑡; 𝑿) = {1 + 𝑡 𝑘 ∗ 𝑒𝑥𝑝(−𝑏0 − 𝑏1 𝑋1 − 𝑏2 𝑋2 … − 𝑏𝑘 𝑋𝑘 )}−1
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𝑆(𝑡; 𝑿) = {1 + 𝑡 0.7 exp(−4.29 + 0.03𝑋1 − 0.25𝑋21 − 0.11𝑋22 − 0.22𝑋23 + 0.25𝑋24 + 0.09𝑋3
− 1.14𝑋41 − 0.84𝑋42 − 0.42𝑋43 − 2.06𝑋51 − 1.65𝑋52 − 0.86𝑋53 + 0.13𝑋61
+ 0.39𝑋62 + 0.0004𝑋7 )}−1
Table 4.8 Analysis of MLEs for Log-Normal Distribution

Analysis of Maximum Likelihood Parameter Estimates
Parameter
Intercept
AGE

95% Confidence Pr >
Limits
ChiSq

Estimate S. E.
4.1885 0.0877

4.0167

4.3604 <.0001

-0.0277 0.0006 -0.0289 -0.0265 <.0001

GRADE

0.2947 0.0343

0.2274

0.3619 <.0001

GRADE

0.1404 0.0299

0.0818

0.1990 <.0001

GRADE

-0.2083 0.0300 -0.2670 -0.1495 <.0001

GRADE

-0.2638 0.0565 -0.3746 -0.1531 <.0001

GRADE
NUMPRIMS

0.0000

.

.

.

.

-0.0929 0.0139 -0.1201 -0.0656 <.0001

TREATMENT

1.2631 0.0580

1.1495

1.3768 <.0001

TREATMENT

0.9212 0.0574

0.8088

1.0337 <.0001

TREATMENT

0.4702 0.1060

0.2624

0.6780 <.0001

TREATMENT

0.0000

.

.

STAGE

2.1276 0.0447

2.0400

2.2151 <.0001

STAGE

1.6874 0.0438

1.6015

1.7733 <.0001

STAGE

0.8968 0.0493

0.8002

0.9933 <.0001

STAGE

0.0000

.

.

.

.

.

.

RACE

-0.1385 0.0243 -0.1861 -0.0909 <.0001

RACE

-0.3934 0.0325 -0.4571 -0.3298 <.0001

RACE
TUMOR_SIZE
Scale

0.0000

.

.

.

.

-0.0004 0.0001 -0.0006 -0.0002 <.0001
1.3005 0.0075
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1.2859

1.3154

Table 4.9 Analysis of MLEs for Log-Logistic Distribution

Analysis of Maximum Likelihood Parameter Estimates
Parameter

Estimates S. E.

95% Confidence
Limits

Pr >
ChiSq

Intercept

4.2928

0.0837

4.1287

4.4568

<.0001

AGE

-0.0277

0.0006

-0.0288

-0.0266

<.0001

GRADE

0.2501

0.0316

0.1881

0.3121

<.0001

GRADE

0.1071

0.0274

0.0534

0.1607

<.0001

GRADE

-0.2197

0.0275

-0.2736

-0.1658

<.0001

GRADE

-0.2483

0.0529

-0.3519

-0.1446

<.0001

GRADE

0.0000

.

.

.

.

NUMPRIMS

-0.0863

0.0127

-0.1112

-0.0614

<.0001

TREATMENT

1.1434

0.0567

1.0323

1.2545

<.0001

TREATMENT

0.8498

0.0562

0.7397

0.9599

<.0001

TREATMENT

0.4233

0.1025

0.2224

0.6242

<.0001

TREATMENT

0.0000

.

.

.

.

STAGE

2.0563

0.0426

1.9727

2.1398

<.0001

STAGE

1.6454

0.0418

1.5635

1.7274

<.0001

STAGE

0.8608

0.0467

0.7692

0.9524

<.0001

STAGE

0.0000

.

.

.

.

RACE

-0.1313

0.0231

-0.1767

-0.0860

<.0001

RACE

-0.3862

0.0305

-0.4460

-0.3263

<.0001

RACE

0.0000

.

.

.

.

0.0001

-0.0006

-0.0002

<.0001

0.0045

0.6899

0.7076

TUMOR_SIZE -0.0004
Scale

0.6987
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4.5.6.2 Lognormal and Log-Logistic Residual Plots
To evaluate the goodness of fit for the lognormal and log-logistic models we performed a
residual analysis for observed and fitted data. The result shows that the mean residual for
lognormal is 0.3740, with a standard deviation of 0.3737 and range of 5.258. Log-logistic
distribution has a mean residual of 0.3770, with a standard deviation of 0.3357 and a range of
4.608. Residual graphs of survival functions for lognormal and log-logistic parametric models
are shown in Figure 4.5 and Figure 4.6 respectively.
Clearly the lognormal is slightly parabolic and the points does not fall close to the
straight line which explains that lognormal is not the best fit for this data. From Figure 4.6
below, the graphical check of residual analysis for the log-logistic model, the graph is almost
linear and hence is the winner parametric model among all others.

Figure 4.5 Residual plot for log-normal distribution
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Figure 4.6 Residual plot for log-logistic distribution

4.5.7 Generalized Gamma Distribution
The survival function of the gamma distribution is the nested form of number of other
distributions which is given by the equation below. Note that this model changes to lognormal as 𝑝 → ∞; Weibull when 𝑘 𝑒𝑞𝑢𝑎𝑙𝑠 𝑡𝑜 1; Exponential when 𝑘 𝑎𝑛𝑑 𝜎 𝑒𝑞𝑢𝑎𝑙𝑠 𝑡𝑜 1;
regular gamma distribution if 𝑝 𝑒𝑞𝑢𝑎𝑙𝑠 𝑡𝑜 1. The main disadvantage of this generalized
gamma distribution is slow and difficult to converge.

𝑙𝑛𝑇𝑖 −𝜆

𝑆(𝑡) = 1 − Γ {𝑘, 𝑘𝑒𝑥𝑝 [

𝜎

𝑝0.5

]}

4.5.7.1 Fitting Gamma Distribution
The survival functions for Gamma parametric model are given by equations below. Table
4.10 has the analysis of the maximum likelihood estimation of parameters of the gamma model
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for breast cancer patients. Due to complexity we haven’t given the fitted gamma survival
function. The residual plot given in Figure 4.7, the data does not fall close to a straight line, so
we conclude that gamma is not a best fit parametric model.
𝑥 (𝜆𝑘−1 𝑒 −𝑥 )

𝑆(𝑡; 𝑿) = 1 − 𝜙𝑘 (𝜆𝑡) Where 𝜙𝑘 (𝜆𝑡) = ∫0 (

Γ(𝑘)

)

Figure 4.7 Residual plot for gamma distribution

4.5.8 Selection of best fit parametric model
We use the model selection criteria discussed in section 4.4.1 to select the best parametric
model. From the previous sections, by performing the residual analysis for the fitted parametric
models log-logistic parametric model performed better than other models. Also from the Table
4.9, we identify that the log-logistic model has the lowest AIC and highest likelihood values
performs better than other models. This supports our choice of log-logistic model selection.
From Table 4.9, we see that Gamma model is also performing close to log-logistic. To address
this concern, we computed the likelihood ratio test statistic to compare these models. The test
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statistic value as 31.21 and the corresponding p-value is 0.0001 which concludes that log-logistic
is better. Comparison of maximum likelihood estimates for all parametric models is given in
Table 4.10.
Based on the estimates of log-logistic model provided in the Table 4.10, when compared
to women treated with surgery, those who received no treatment has better survival estimates
compared with radiation followed by combination of radiation and surgery. However, from this
model, tumor size, marital status, race has no much effect on the breast cancer.

Table 4.10 Goodness of fit for parametric models

Distribution

Log-Likelihood

AIC

Gamma

-43730.415

87506.83

Log-Normal

-43957.83687

87959.67

Weibull

-43961.92163

87967.84

Exponential

-44259.26034

88560.52

Log-Logistic

-43714.80892

87473.62

Table 4.11 Summary of MLE results for fitted parametric models

Parameter

DF Gamma Log-Normal Weibull Exponential Log-Logistic

Intercept

1 4.6896

4.1885

5.2216

5.3589

4.2928

Age

1 -0.0284

-0.0277

-0.0287 -0.0321

-0.0277

Grade

1

1 0.2747

0.2947

0.2513

0.3171

0.2501

Grade

2

1 0.1206

0.1404

0.0974

0.1368

0.1071

Grade

3

1 -0.1972

-0.2083

-0.1761 -0.1723

-0.2197

Grade

4

1 -0.2355

-0.2638

-0.2086 -0.2108

-0.2483

Grade

9

0 0.0000

0.0000

0.0000

0.0000

Numprims

1 -0.0815

-0.0929

-0.0694 -0.0851

-0.0863

Treatment 1

1 1.0637

1.2631

0.8678

0.9496

1.1434

Treatment 2

1 0.7573

0.9212

0.5897

0.6257

0.8498
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0.0000

Table 4.12 (Continued) Summary of MLE results for fitted parametric models

Parameter

DF Gamma Log-Normal Weibull Exponential Log-Logistic

Treatment 3

1 0.3489

0.4702

0.2360

0.2614

0.4233

Treatment 4

0 0.0000

0.0000

0.0000

0.0000

0.0000

Stage

1

1 1.9563

2.1276

1.6954

1.8855

2.0563

Stage

2

1 1.5448

1.6874

1.3236

1.4624

1.6454

Stage

3

1 0.7996

0.8968

0.6660

0.7280

0.8608

Stage

4

0 0.0000

0.0000

0.0000

0.0000

0.0000

Race

1

1 -0.1340

-0.1385

-0.1255 -0.1512

-0.1313

Race

2

1 -0.3790

-0.3934

-0.3465 -0.3980

-0.3862

Race

3

0 0.0000

0.0000

0.0000

0.0000

1 -0.0004

-0.0004

-0.0003 -0.0004

-0.0004

1 1.0748

1.3005

0.8484

0.6987

Tumor size
Scale

0.0000

1.0000

4.6 Semi Parametric Analysis: Cox PH regression
The main disadvantage of non-parametric analysis is that it can only compare the survival
functions of a limited number of groups whereas the parametric analysis has disadvantage of two
assumptions as discussed in previous section. There is an intermediate technique whereby only
an assumption is made about the way that the explanatory variables. This technique is called
semi-parametric analysis, or Cox-regression. Proportional hazards regression (56) assumes that
different groups have proportional hazard functions. Suppose with two groups A and B, there is a
common hazard function ℎ(𝑡), which applies to group A. Being in group B multiplies the hazard
by 𝑟. i.e. ℎ𝑠 (𝑡) = 𝑟. ℎ𝐴 (𝑡)
Proportional hazards regression estimates 𝑟 without estimating ℎ(𝑡). Since hazards are
chances, this means that the ratio of the hazard functions can be interpreted as a relative risk or
relative rate.
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𝑟=

ℎ𝑠 (𝑡)
ℎ𝐴 (𝑡)

This relative risk type ratio is very desirable in explaining the risk of events for certain
categories of covariates or variable of interest.

4.6.1 Assumptions underlying Proportional Hazard Modeling
1. There exists a baseline hazard function ℎ𝑜 (𝑡)common to all individuals in all the study
groups. The baseline hazard function captures the shape of the hazard function.
2. When there is a covariate (dichotomous variable) the hazard function becomes the
exponential of the parameter of interest which is termed as the exponential distribution under
PH modeling.
3. Another attractive feature of Cox regression is not assuming the distributions as in the case of
parametric regression. Instead refers to the fact that the hazard functions are multiplicatively
related.
4. Explanatory variables act only on the 𝑟 not on the baseline hazard.
4.6.2 Proportional Hazard Modeling
The formulation of Cox’s regression model assumes the hazard of the subject 𝑖 at the
time 𝑡 of the form
ℎ1 (𝑡) = ℎ0 (𝑡)exp(𝑋𝑖 𝛽)
ℎ(𝑡|𝑧 )

Given two covariate profiles(𝑍1 ,𝑍2 ) the hazard ratio ℎ(𝑡|𝑧1 ) = 𝑒𝑥𝑝(
2

(𝑍1 −𝑍2 )
𝛽

) is constant in

time. Usually 𝛽 is of the main interest and can be estimated independently by the partial
likelihood approach (57) when right-censored data are observed. This appealing property of the
PH model, together with its great flexibility, has made it one of the most popular models in
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survival analysis during the past three decades. For the two-sample semi-parametric modeling,
the proportional hazards model is perhaps the most widely used model and under this model, the
hazard ratio for the two groups is a constant. Sometimes the constant hazard ratio may be in
questioned and in this case, one can use the proportional odds model, which allows the timedependent hazard ratio. One shortcoming of these models is that they do not apply if the two
hazard or survival functions cross and this can happen in, for example, a medical study where a
Treatment may be effective in long run but can have certain adverse effects during the early
stage. For investigating whether there is really a difference between the two groups or whether
there is really a treatment effect (58), we test the null hypothesis 𝐻0 : 𝛽1 = 0 against the
alternative hypothesis𝐻1 : 𝛽1 ≠ 0. One has to take 𝑇 =

̂1
𝛽
̂1)
𝑆(𝛽

as testing statistic with 𝛽̂1 being the

estimate of 𝛽1 and 𝑆(𝛽̂1 ) being the corresponding standard error. The distribution of the testing
statistic is approximated by the standard normal distribution under the null hypothesis. The null
hypothesis is rejected if 𝑇 ≤ −𝑐 or ≥ 𝑐 .The advantage is that the results can no longer be
influenced by assumptions about time-dependence, since no such assumptions are made. The
disadvantages are that hypotheses about time dependence can no longer be tested and that
parametric analysis yields more precise estimates than the semi-parametric analysis if the
assumptions about the time dependence are correct.

4.6.3 Cox Proportional Hazards Regression for breast cancer data
Using the same breast cancer survival data used in parametric survival analysis, in this
section, we will examine cox regression models for the hazard function ℎ(𝑡). As with other
regression models, the identification of significant covariates and the interpretation of the
estimated model coefficients is of primary interest. We will identify the likelihood that an
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individual alive at time t (with the specific set of covariates as described in parametric survival
modeling section) will experience the event of interest in the next very small time period. The
Cox proportional hazard model (58) is used to determine the difference of survival time between
races, age at diagnosis, stage of cancer, treatment, tumor size, grade, marital status and number
of primary tumors. The variables in the model are introduced stepwise. The fitted Cox model
reached its convergence. The model fit statistics are given below in Table 4.11. The results of
three tests (likelihood, score and Wald tests) given below in Table 4.12 are used to test the
hypothesis of whether the full model with all variables is better than no variables in the model.
The p-value for all the three tests supported the model with all variables is statistically
significant. The parameter estimate values of semi parametric cox regression model along with
hazard ratios are given in Table 4.14.
From the Table 4.14, we can say that every year of age hazard increases by 3%. White
women have 16% and African women has 50% greater hazard than other race women. When
compared to women who are treated with surgery, those who are treated with radiation has
50.5% and women who did not receive any treatment has 64% lower hazard rate. While the
combination of both surgery and radiation has 24% lower hazard rate. Type 3 tests are used to
test whether there are any differences in event rate across any of the levels of the covariates used
in the model. P-values reported in Table 4.13 indicate that there are significant differences in
mortality between the levels of covariates. The fitted Cox PH Survival and Hazard equations for
breast cancer patients are:

ℎ𝑖 (𝑡) = ℎ0 (𝑡)𝑒𝑥𝑝(0.033𝑋1 − 0.31𝑋21 − 0.13𝑋22 + 0.19𝑋23 + 0.23𝑋24 + 0.082𝑋3 − 1.03𝑋41
− 0.70𝑋42 − 0.26𝑋43 − 2.01𝑋51 − 1.57𝑋52 − 0.78𝑋53 + 0.15𝑋61 + 0.41𝑋62
+ 0.0003𝑋7 )
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𝑡

𝑆𝑖 (𝑡) = exp (− ∫ {ℎ0 (𝑡)𝑒𝑥𝑝(0.033𝑋1 − 0.31𝑋21 − 0.13𝑋22 + 0.19𝑋23 + 0.23𝑋24 + 0.082𝑋3
0

− 1.03𝑋41 − 0.70𝑋42 − 0.26𝑋43 − 2.01𝑋51 − 1.57𝑋52 − 0.78𝑋53 + 0.15𝑋61
+ 0.41𝑋62 + 0.0003𝑋7 )} 𝑑𝑢)
Table 4.13 Cox regression model fit statistics

Model Fit Statistics
Criterion

Without
With
Covariates Covariates

-2 LOG L

368614.59

358231.90

AIC

368614.59

358269.90

SBC

368614.59

358417.91

Table 4.14 Test results for beta coefficients

Testing Null Hypothesis: BETA=0
Test

Chi-Square DF Pr > ChiSq

Likelihood Ratio 10382.6831

19

<.0001

Score

14594.0408

19

<.0001

Wald

12414.3302

19

<.0001

Table 4.15 Type III tests for levels of covariates

Type 3 Tests
Effect

DF Wald Chi-Square Pr > ChiSq

Age

1

2677.5352

<.0001

M_status

5

219.4995

<.0001

Grade

4

543.3288

<.0001

Race

2

161.6861

<.0001

Treatment

3

677.9500

<.0001

Stage

3

3555.2608

<.0001

Numprims

1

36.2624

<.0001

Tumor size

1

21.5580

<.0001
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Table 4.16 Cox parameter estimates and hazard ratios

Parameter Standard
DF
Estimate
Error

Parameter

Age

95% Hazard
Hazard Ratio
Ratio
Confidence
Limits

1

0.03328

0.00064

1.034 1.033

1.035

Grade

1

1

-0.31020

0.03505

0.734 0.685

0.786

Grade

2

1

-0.12712

0.02937

0.880 0.831

0.932

Grade

3

1

0.19351

0.02919

1.212 1.145

1.284

Grade

4

1

0.23365

0.05602

1.259 1.128

1.406

Race

1

1

0.15031

0.02654

1.163 1.104

1.225

Race

2

1

0.40886

0.03375

1.504 1.408

1.607

Treatment

1

1

-1.03141

0.05072

0.363 0.329

0.401

Treatment

2

1

-0.70261

0.04975

0.505 0.458

0.557

Treatment

3

1

-0.25560

0.08686

0.763 0.644

0.905

Stage

1

1

-2.01361

0.03759

0.138 0.128

0.148

Stage

2

1

-1.57326

0.03686

0.213 0.198

0.229

Stage

3

1

-0.78178

0.04177

0.459 0.423

0.498

Numprims

1

0.08168

0.01353

1.085 1.056

1.114

Tumor size

1

0.000384 0.0000826

1.000 1.000

1.001

Finally we obtained the Cox PH survival function model for each of the three races
respectively. The fit equations are given below.
Cox PH Survival and Hazard equations for White woman
ℎ𝑖 (𝑡) = ℎ0 (𝑡)𝑒𝑥𝑝(0.04𝑋1 − 0.32𝑋21 − 0.11𝑋22 + 0.22𝑋23 + 0.28𝑋24 + 0.08𝑋3 − 0.94𝑋41
− 0.56𝑋42 − 0.17𝑋43 − 1.97𝑋51 − 1.54𝑋52 − 0.81𝑋53 + 0.0005𝑋7 )
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𝑡

𝑆𝑖 (𝑡) = exp (− ∫ {ℎ0 (𝑡) exp(0.04𝑋1 − 0.32𝑋21 − 0.11𝑋22 + 0.22𝑋23 + 0.28𝑋24 + 0.08𝑋3
0

− 0.94𝑋41 − 0.56𝑋42 − 0.17𝑋43 − 1.97𝑋51 − 1.54𝑋52 − 0.81𝑋53
+ 0.0005𝑋7 )} 𝑑𝑢)
Cox PH Survival and Hazard equations for African American woman
ℎ𝑖 (𝑡) = ℎ0 (𝑡)𝑒𝑥𝑝(0.02𝑋1 − 0.28𝑋21 − 0.25𝑋22 + 0.03𝑋23 + 0.11𝑋24 + 0.08𝑋3 − 1.22𝑋41
− 1.02𝑋42 − 0.72𝑋43 − 2.07𝑋51 − 1.62𝑋52 − 0.75𝑋53 + 0.00007𝑋7 )
𝑡

𝑆𝑖 (𝑡) = exp (− ∫ {ℎ0 (𝑡)𝑒𝑥𝑝(0.02𝑋1 − 0.28𝑋21 − 0.25𝑋22 + 0.03𝑋23 + 0.11𝑋24 + 0.08𝑋3
0

− 1.22𝑋41 − 1.02𝑋42 − 0.72𝑋43 − 2.07𝑋51 − 1.62𝑋52 − 0.75𝑋53
+ 0.00007𝑋7 )} 𝑑𝑢)
Cox PH Survival and Hazard equations for other race woman
ℎ𝑖 (𝑡) = ℎ0 (𝑡)𝑒𝑥𝑝(0.02𝑋1 − 0.18𝑋21 − 0.11𝑋22 + 0.2𝑋23 − 0.08𝑋24 + 0.08𝑋3 − 1.03𝑋41
− 0.95𝑋42 − 0.03𝑋43 − 2.12𝑋51 − 1.59𝑋52 − 0.72𝑋53 + 0.0003𝑋7 )
𝑡

𝑆𝑖 (𝑡) = exp (− ∫ {ℎ0 (𝑡)𝑒𝑥𝑝(0.02𝑋1 − 0.18𝑋21 − 0.11𝑋22 + 0.2𝑋23 − 0.08𝑋24 + 0.08𝑋3
0

− 1.03𝑋41 − 0.95𝑋42 − 0.03𝑋43 − 2.12𝑋51 − 1.59𝑋52 − 0.72𝑋53
+ 0.0003𝑋7 )} 𝑑𝑢)
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Table 4.17 Estimates of Cox and Log-logistic models

Parameter

Age

DF Cox

1

Log-Logistic

Estimates

Hazard Estimates Hazard

0.03328

1.034

-0.0277

1.028087

Grade

1 1

-0.31020

0.734

0.2501

1.284154

Grade

2 1

-0.12712

0.880

0.1071

1.113046

Grade

3 1

0.19351

1.212

-0.2197

1.245703

Grade

4 1

0.23365

1.259

-0.2483

1.281844

Race

1 1

0.15031

1.163

-0.1313

1.14031

Race

2 1

0.40886

1.504

-0.3862

1.471379

Treatment

1 1

-1.03141

0.363

1.1434

3.137417

Treatment

2 1

-0.70261

0.505

0.8498

2.339179

Treatment

3 1

-0.25560

0.763

0.4233

1.526992

Stage

1 1

-2.01361

0.138

2.0563

7.816993

Stage

2 1

-1.57326

0.213

1.6454

5.183083

Stage

3 1

-0.78178

0.459

0.8608

2.365052

0.08168

1.085

-0.0863

1.090133

Tumor size

0.000384

1.000

-0.0004

1.000384

AIC

358269.90

87473.62

Log likelihood

-179115.95

-43714.81

Numprims

1
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4.7 Comparison of Survival Curves
The Table 2.16 below has the details about all the fit models with and without covariates.
Log-logistic model outperformed Cox. However based on the data and attributable variables
available, one can choose their best model. Table 2.15 has the comparison of Log-logistic and
Cox PH estimates along with the hazard ratios.
Table 4.18 Comparison of Parametric and Cox PH models

Models

Without Covariates

Distribution Parameters

-Log
Likelihood

With Covariates
AIC

Parameters

-Log
Likelihood

AIC

Gamma

3

49170.0137

98346.03

16

43730.415

87506.83

Log-Normal

2

49366.8675

98737.74

15

43957.837

87959.67

Weibull

2

49244.9480

98493.90

15

43961.9216

87967.84

Exponential

1

49280.6023

98563.20

14

44259.2603

88560.52

Log-Logistic

2

49175.7691

98355.54

15

43714.8089

87473.62

Cox PH

-

184307.293 368614.59

16

179115.950 358269.90

4.8 Conclusion
Women who are treated with radiation alone have a median survival of 154 months. And
women treated with surgery alone and both radiation & surgery reported a median survival of 25
months. Non-parametric method for survival, based on the treatment indicated that the
combination of radiation and surgery has the same effect on survival as treated with surgery
alone. Also from the results of Table 4.2, women in stage-4 breast cancer can be advised to stay
away from any treatment for a better survival. Financially, this could really save so much for
women. Further we investigated the effect of treatment stage wise. It is an interesting observation
that women who are identified with malignant breast cancer tumor, but have not received any
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treatment has more survival rate when compared to women who are treated with either radiation
or surgery or combination of both.
This result is also supported by the results in Table 4.2. After analyzing the breast cancer
data using the non-parametric Kaplan Meier method, we further performed a multivariate
approach parametrically and semi-parametrically. In parametric survival modeling, we modeled
the data using exponential, Weibull, log-normal, log-logistic and generalized gamma. Based on
the AIC and log-likelihood comparison, log-logistic resulted as the best fit model for the data.
Residual plots for the log-logistic model also fall close to the straight line, supporting our choice
of parametric model.
Both intercepts and beta coefficients for almost all variables except for the women who
are singled, widowed and separated, in the model are significantly differ from 0 at 0.05 level.
Finally, we modeled Cox semi-parametric regression model and tabulated the hazard results with
95% confidence intervals. Neither parametric nor the Cox semi-parametric models provided any
evidence about significant differences in covariates stage, race, grade and treatment. Based on
AIC, as anticipated, all parametric models were performed better than the cox models.
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CHAPTER FIVE
Breast Cancer Stage Classification using Multilayer Neural Networks using various
Activation functions

5.1 Introduction
Artificial Neural Networks (also called connectionist models or parallel distributed
processing systems) whose architecture and operation are inspired from our knowledge about
biological neural cells (neurons) in the brain (59). Artificial Neural Networks (ANNs) can be
described either as mathematical and computational models for non-linear function
approximation, data classification, clustering and non-parametric regression or as simulations of
the behavior of collections of model biological neurons. These are not real neurons in the sense
that they do not model the biology, chemistry or physics of real neuron. They do, however,
model several aspects of information combining and pattern recognition behavior of real neurons
in a simple yet meaningful way.
Conceptually, Artificial Neutral Networks are computing constructs which mimic the
process of the human brain.
Mathematically, they are a system of linked parallel equations which are solved
simultaneously and iteratively (60).
Artificial Neural Networks (ANNs) or in short neural networks (NNs), like people,
learn by example. An ANN is configured for a specific application, such as pattern recognition
or data classification (61), through a learning process. Learning in biological systems involves
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adjustments to the synaptic connections that exist between the neurons. This is true for ANNs
as well.
The power and usefulness of ANNs have been demonstrated in several applications
including speech synthesis (62), diagnostic problems and medicine (63), business and finance,
robotic control (64), signal processing (65), computer vision and many other problems that fall
under the category of pattern recognition.
Neural Networks has a large appeal to many researchers due to their great closeness to
the structure of the brain, a unique characteristic not shared by many traditional systems.
In an analogy to the brain, an entity made up of inter connected neurons, neural networks
are made up of interconnected processing elements called units (or nodes), which respond in
parallel to a set of input signals given to each unit. The unit is the equivalent to its brain
counterpart, the neuron.

A typical neural network consists of four main parts:
4. Processing units {𝑢𝑗 }, where each 𝑢𝑗 has a certain activation level 𝑎𝑗 (𝑡) at any point in time 𝑡.
5. Weighted interconnection between the various processing units which determine how the
activation of one unit leads to input for another unit.
6. An activation rule which acts on the set of input signals at a unit to produce a new output
signal, or activation.
7. Optionally, a learning rule that specifies how to adjust weights for a given input output pair.
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Artificial Neural Networks
MLPs, RBFs, Hopfield, etc

Interconnections
Feed Forward,
Feed backward,
Recurrent, etc

Learning
Supervised,
Unsupervised
Reinforcement

Activation function
Hyperbolic Tangent,
Sigmoid, Softmax,
etc

Figure 5.1 Architecture of ANN

5.1.1 Questions of Interest
Q1: Are MLP neural networks applicable to stage classification problems in Breast
cancer research?
Q2: Under what conditions can MLP type neural networks be applied to stage
classification problems in breast cancer data?
Q3: What are the different kind of activation functions available in MLP neural
networks?
Q4: Which activation function in the training and testing of the ANN give the better
performance?
Q5: What is the best activation function that can be applied to neural networks for stage
classification problems in Breast cancer research?
Q6: How to evaluate the identified MLP type neural networks with different activation
functions to classify breast cancer stages?
Q7: After dropping the attributable variables from the full model that contribute less in
breast cancer stage classification, does the reduced model perform the same as the full model?
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5.2 The First Step: McCulloch-Pitts Model
Using one of the characteristics of the biological neuron, McCulloch and Pitts (66)
proposed a model for artificial neuron. The neuron model proposed by them is given in the
Figure 5.2 below and is the one that widely used in ANNs with some minor modifications on it.
The artificial neuron given in the Figure 5.2 has N inputs, denoted as 𝑢1 , 𝑢2 , … , 𝑢𝑛 . Each
line connecting these inputs to the neuron is assigned a weight, which are denoted as
𝑤1 , 𝑤2 … , 𝑤𝑛 respectively. Weights in the artificial neuron corresponding to the synaptic
connections in biological neurons. The threshold in artificial neuron is usually represented by θ
and the activation corresponding to the graded potential is given by the formula:
𝑁

𝑎 = (∑ 𝑢𝑖 𝑤𝑖 ) + 𝜃
𝑖=1

𝑢1

w1
Out

𝑢2

𝑁

w2

x=f(a)

(∑ 𝑢𝑖 𝑤𝑖 ) + 𝜃
𝑖=1

𝑢𝑁

wN

Figure 5.2 Mc Culloch-Pitts Model

5.3 A brief history of ANNs
Neural network simulations appear to be a recent development. However, this field was
established before the advent of computers, and has survived at least one major setback and several
areas. Many important advances have been boosted by the use of inexpensive computer
emulations. Following an initial period of enthusiasm, the field survived a period of frustration
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and disrepute. During this period when funding and professional support was minimal, important
advances were made by relatively few researchers. These pioneers were able to develop
convincing technology which surpassed the limitations identified by Minsky and Papert. Minsky
and Papert (67), published a book in 1969 in which they summed up a general feeling of frustration
against neural networks among researchers, and was thus accepted by most without further
analysis. Currently, the neural network field enjoys a resurgence of interest and a corresponding
increase in funding.

5.4 Timeline of ANN

1943

McCulloch and Pitts (66) proposed the McCulloch-Pitts neuron model.

1949 Hebb published his book “The Organization of Behavior” in which the Hebbian learning
rule was proposed.
1958

Rosenblatt introduced the simple single layer networks called Perceptrons.

1969 Minsky and Papert’s (67) book “Perceptrons” demonstrated the limitation of single layer
perceptrons, and almost the whole field went into hibernation.
1970’s and 1980’s: ANN renaissance
1982

Hopfield published a series of papers on Hopfield networks.

1982

Kohonen developed the self-Organizing Maps that now bear his name.

1986 The Back-Propagation learning algorithm for Multi-Layer Perceptrons was rediscovered and the whole field got attention.
1989

Tsividis: Implemented Neural Network on a chip

1990 The sub-field of Radial Basis Function Networks was developed.
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2000 The power of Ensembles of Neural Networks and support vector Machines becomes
apparent.

5.5 Inspiration for ANN: Biological Prototype
Much is still unknown about how the brain trains itself to process information, so theories
abound (Figure 5.4).In the human brain, a typical neuron collects signals from others through a
host of fine structures called Dendrites. The neuron sends out spikes of electrical activity through
a long, thin stand known as an axon, which splits into thousands of branches. At the end of each
branch, a structure called a synapse converts the activity from axon into electrical effects that
inhibit or excite activity in the connected neurons. When a neuron receives excitatory input that
is sufficiently large compared with its inhibitory inputs, it sends a spike of electrical activity
down its axon (Figure 5.3). Learning occurs by changing the effectiveness of the synapse so that
the influence of one neuron on another changes.

AXON HILLOCK

AXON

SOMA

NUCLEUS

AXON TERMINAL
AXON BRANCHING

SYNAPSE

Figure 5.3 Biological Neuron
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PARIETAL LOBE

CEREBRUM

OCCIPITAL LOBE

FRONTAL LOBE

CEREBELLUM
TEMPORAL LOBE
BRAIN STEM

Figure 5.4 Human Brain

5.6 Brain versus Computers: Some interesting numbers
1. There are approximately 10 billion neurons in the human cortex, compared with thousands
of processors in the most powerful parallel computers.
2. Each biological neuron is connected to several thousands of other neurons, similar to the
connectivity in powerful parallel computers.
3. Lack of processing units can be compensated by speed. The typical operating speeds of
biological neurons (68) is measured in milliseconds (10–3s), while a silicon chip can
operate in nanoseconds (10–9s).
4. The human brain is extremely energy efficient, using approximately 10-6 joules per
operation per second, where as the best computers today use around 10–16 joules per
operation per second.
5. Brains have been evolving for tens of millions of years; computers have been evolving for
tens of decades.
96

5.7 ANN Types

Feed forward: Single Layer Perceptron (69), MLP, ADALINE (Adaptive Linear Neuron)
(70), RBF.
Self-Organized: SOM (Kohonen Maps).
Recurrent: Simple Recurrent Network, Hopfield Network (71).
Stochastic: Boltzmann machines (72), RBM.
Modular: Committee of Machines, Associative Neural Networks (ASNN), Ensembles.
Others: Instantaneously trained, Spiking Neural Networks (SNN) (73), Dynamic,
Cascades, Neuro Fuzzy (74), PPS, GTM (75).
5.8 Learning methods in ANN
As listed in previous section, there are many forms of neural networks. Most operate by
passing neural ‘activations’ through a network of connected neurons. One of the most powerful
features of neural networks is their ability to learn and generalize from a set of training data.
They adapt the strengths/ weights of the connections between neurons so that the final output
activations are correct.

There are three broad types of learning:
1) Supervised learning (i.e., learning with a teacher)
2) Unsupervised learning (i.e., learning with no help)
3) Reinforcement learning (i.e., learning with limited feedback)
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Single Layer Perceptron

ANN

Feed-Forward Networks
Multilayer Perceptron

Self Organizing Maps
Feedback Networks
Bayesian Regularized NN

Figure 5.5 ANN Architecture

Learning Methods

Supervised (Error
Based)

Unsupervised

Stochastic

Hebbian

Gradient Descent
learning

Competitive

Figure 5.6 Learning Methods in ANN
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Reinforcement
(Output based)

5.8.1 Supervised learning
Which incorporates an external teacher, so that each output unit is told what its desired
response to input signals ought to be. In this mode, the actual output of a neural network is
compared to the desired output. Weights, which are usually randomly set to begin with, are then
adjusted by the network so that the next iteration, or cycle, will produce a closer match between
the desired and the actual output. The learning method tries to minimize the current errors of all
processing elements. This global error reduction is created over time by continuously modifying
the input weights until acceptable network accuracy is reached. Paradigms of supervised learning
include error-correction learning reinforcement learning and stochastic learning (76).
With supervised learning, the Artificial Neural Network must be trained before it
becomes useful. Training consists of presenting input and output data to the network. That is, for
each input set provided to the system the corresponding desired output set is provided as well.
This training is considered complete when the neural network reaches a user defined
performance level.
An important issue concerning supervised learning is the problem of error convergence,
i.e., the minimization of error between the desired and computed unit values. The aim is to
determine a set of weights which minimizes the error. One well-known method, which is
common to many learning paradigms is the Least Mean Square (LMS) convergence (77).

5.8.2 Unsupervised learning
Uses no external teacher and is based upon only local information, it is also referred to as
self-organization, data presented to the network and detects their emergent collective properties.
Paradigms of unsupervised learning are Hebbian learning and competitive learning. From
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Human Neurons to Artificial Neuron Esther aspect of learning concerns the distinction or not of
a separate phase, during which the network is trained, and a subsequent operation phase. We say
that a neural network learns off-line if the learning phase and the operation phase are distinct. A
neural network learns on-line if it learns and operates at the same time. Usually, supervised
learning is performed off-line, whereas unsupervised learning is performed on-line.
A simple version of Hebbian learning rule (78) is that when unit 𝑖 and unit 𝑗 are
simultaneously excited, the strength of the connection between them increases in proportion to
the product of their activations.
In competitive learning, if a new pattern is determined to belong to a previously
recognized cluster, then the inclusion of the new pattern into that cluster will affect the
representation (e.g., centroid) of the cluster. This will in turn change the weights characterizing
the classification network. If the new pattern of ‘input-outputs’ determined to belong to none of
the previously recognized cluster, then (the structure and the weights of) the network will be
adjusted to accommodate the new class (cluster).

5.8.3 Reinforcement learning
For many applications, the desired output may not be known precisely. Other learning
law have been developed based on the information whether the response is correct or wrong.
This mode of learning is called reinforcement learning or learning with critic.
There are many situations where the desired output for a given input is not known. Only
the binary result that the output is right or wrong may be available. This output is called
reinforcement signal. This signal only evaluates the output. The learning based on this evaluate
signal is called reinforcement learning. Since this is evaluative and not instructive, it is also
called learning with critic as opposed to learning with teacher in the supervised learning.
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5.9 Multilayer Perceptron and Radial Basis Function
Multilayer perceptrons (MLPs) and radial basis function (RBF) networks are the two
most commonly-used types of feed forward network. They have much more in common than
most of the neural network literature would suggest. The only fundamental difference is the way
in which hidden units combine values coming from preceding layers in the network--MLPs use
inner products, while RBFs use Euclidean distance. There are also differences in the customary
methods for training MLPs and RBF networks, although most methods for training MLPs can
also be applied to RBF networks. Furthermore, there are crucial differences between two broad
types of RBF network, the ordinary RBF networks and the normalized RBF networks that are
ignored in most of the neural network literature. These differences have important consequences
for the generalization ability of the networks, especially when the number of inputs is large. Our
focus in this chapter will be on MLPs. A network with three layers: input, hidden and output
layers.
An activation function 𝑓(𝑥,𝑤𝑖) connects the weights 𝑤𝑖of a neuron I to the input x and
determines the activation or the state of the neuron. An input function x of the formal neuron I
corresponds to the incoming activity of the neuron, the weight w represents the effective
magnitude of information transmission between neurons, the activation function 𝑓(𝑥,𝑤𝑖) describes
the main computation performed by a biological neuron and the output function 𝑜𝑢𝑡𝑖 corresponds
to the overall activity transmitted to the next neuron in the processing stream.

5.10 Activation Functions
The crucial step in MLP neural network structure is generating the net inputs by using a
scalar-to-scalar function which is known as the "activation function" or "threshold function" or
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"transfer function" (79). These activation functions are used to limit the amplitude of the output
of a neuron. The typical activation functions which are used to solve the non-linear problems are
sigmoid, tangent, softmax, radial basis functions among others. These functions further process
the output of the neuron after initial processing has taken place and are non-linear in nature by
transforming the weighted sum of inputs to an output value and do the final mapping. In most
cases these functions squash the amplitude range to a limited value probably the normalized
value. Interestingly the outputs of these functions are further processed by running more number
of iterations unless the network attains the desired convergence. In back propagation learning the
functions implemented should have the characteristics like the continuous, differentiable, and
monotonically non-decreasing and output should be bounded.
As mentioned earlier, ANNs are mostly used in modeling nonlinear data. Neural
networks because of its nonlinear structure are used either to approximate a posteriori
probabilities for clustering/classification or to approximate probability densities of the training
data (80, 81). Nonlinearity is introduced into an MLP network in the form of an activation
function for the hidden units. The nonlinearity in the network is the reason why MLPs are so
powerful. Below are few important papers surveyed which show that the choice of transfer
functions is considered by some experts to be as important as the network architecture and
learning algorithm.
G. Cybenko (1989), K. Hornik et al. (1989) in their research articles (82, 83) discussed
about using sigmoidal functions generating sigmoidal outputs as universal approximators.
However E. J. Hartman, et al. (1990) and J. Park, et al. (1991) also termed Gaussian outputs also
as universal approximators (82, 83). Hartman and Keeler (1991) proposed a new activation
function called Gaussian bars (84). Pao (1989) in his book “Adaptive Pattern Recognition and
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Neural Networks” discussed about using a combination of various activation functions (85).
Simon Haykin and Leung (1993) were very successful with using radial transfer functions (86).
Dorffner (1994) using conic section function networks introduced new transformation
functions that change smoothly from sigmoidal to Gaussian-like (87). Girauld, et al. (1995)
introduced simplified Gaussian functions called Lorentzian transfer functions which are widely
used in many research works (88).
Two most popular feed forward neural networks models, the multi-layer perceptron
(MLP) and the Radial Basis Function (RBF) networks, are based on specific architectures and
the transfer functions. Below are few activation functions in detail.

5.10.1 Identity Function
The Identity function is also known a linear function. The output of the function is same
as the input variable. Sometimes a constant is used to multiply it to form a linear function with
scaled magnitude. The activation function needs to introduce non linearity in to the networks for
the network to be robust.
f ( x)  x

f ( x)  kx Where k is a scaling constant

Figure 5.7 Identity Function
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5.10.2 Binary Step Function
This function is also known as the Heaviside function or threshold function or hard limit
function, with threshold θ. The output is always a binary value and it is decided by the function.

0 if x  
f ( x)  
 if x  


Figure 5.8 Binary Step Function

5.10.3 Saturating linear function
This function is also known as ramp function or piece wise linear sigmoid function (89)
combines the Heaviside function with a linear output function.
0,
𝑥≤0
𝑓(𝑥) = {𝑥, 0 < 𝑥 < 1
1,
𝑥≥1

Figure 5.9 Ramp Function
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5.10.4 Sigmoid Functions
Sigmoidal output functions smooth out many shallow local minima in the total output
functions of the network. For classification type of problems this may be desirable, but for
general mappings it limits the precision of the adaptive system (90). This is the most commonly
used transfer function in MLP as it gives good results in most cases and can dramatically reduce
the computation burden of training. The term sigmoid mean a graph which is 'S-shaped' curve. It
is most commonly used function in the neural networks where the training is implemented by
using the back propagation algorithms. The significance of this function is that the computation
capacity for training is reduced and can be distinguished easily.
Uni-polar sigmoid
The output of this function is bounded to [0, 1]. The function gets zero to as the value of
x tends to infinity in the negative side. Its analytic equation is given below.
𝑓(𝑥) =

1
1 + 𝑒𝑥

Figure 5.10 Uni-polar Sigmoid Function

Bi-Polar Sigmoid Function
The bi-polar sigmoid function is similar to the uni-polar sigmoid except that the limits of
the output range between [-1, 1].
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𝑓(𝑥) =

1 − 𝑒𝑥
1 + 𝑒𝑥

Bipolar binary and uni-polar binary are called as hard limiting activation functions used
in discrete neuron model. Uni-polar continuous and bipolar continuous are called soft limiting
activation functions are called sigmoidal characteristics.

1

0
-1

Figure 5.11 Bi-Polar Sigmoid function

5.10.5 Hyperbolic Tangent Function

The hyperbolic transfer function also ranges between [-1, 1]. This function is
implemented in the replication of the sigmoid function where the output range is varying
between -1 to 1.
𝑓(𝑥) =

𝑒 𝑥 − 𝑒 −𝑥 sinh 𝑥
=
= tanh 𝑥
𝑒 𝑥 + 𝑒 −𝑥 cosh 𝑥
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1

0
-1

Figure 5.12 Hyperbolic Tangent function

5.10.6 Radial basis functions (RBFs)
As MLP's implement sigmoidal transfer functions, RBFs typically use Gaussian
functions. Both types of networks are universal approximators. This is an important, but almost
trivial property, since any network using non-polynomial transfer functions are always universal
approximators. The speed of convergence and the complexity of these networks to solve a given
problem is more interesting.
𝑔(𝑥, 𝑐) = 𝑔(||𝑥 − 𝑐||)
𝑁

𝑦(𝑥) = ∑ 𝑤𝑖 𝑔(||𝑥 − 𝑐𝑖 ||)
𝑖=1

Where𝑦(𝑥) is represented as a sum of N radial basis functions and each of them
are associated with a different center ci and weighted by an appropriate weight 𝑤𝑖 and 𝑤𝑖 can be
obtained by the matrix methods of linear least squares.(91)
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Figure 5.13 Radial basis function

5.11 Evaluation of model performance
The methods used for the model performance evaluation of different neural networks
include comparison of area under ROC curves, positive predictive values (PPVs) and overall
accuracy. The values of training and testing the full and reduced models were evaluated and
tabulated in the following sections. In the ROC graph the diagonal line represents diagnostic test
where sensitivity equals (1– specificity) which refers that the test has no diagnostic value. A test
where both sensitivity and specificity are close to 1, which in turn will return a ROC value also
close to 1, has good diagnostic ability.
5.11.1 Accuracy, ROC, PPVs
Receiver operating characteristic (ROC) curves (92) are frequently used to compare the
diagnostic qualities of statistical models. For a given confidence threshold, the fraction of
negative outcomes that are correctly identified as negatives is called the true-positive fraction
(TPF = sensitivity) and the fraction of the positive outcomes that are correctly identified is called
the true-negative fraction (TNF = specificity). The false-positive fraction (FPF) and the falsenegative fraction (FNF) are defined in the same way. Confusion matrix generated for a model
gives all these details of classification. For the actually positive and the actually negative
outcomes, probability distributions can be derived for the various states of truth.
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Table 5.1 Classification Table

X
Considered
positive
Considered
negative

Actual State
Positive

Negative

True positive (TP)

False positive (FP)

False negative
(FN)

True negative
(TN)

There are three components to predict the accuracy: the amount and quality of the data,
the predictive power of the prognostic factors, and the prognostic method’s ability to capture the
power of the prognostic factors (93). This study is mainly focused on the area under curve
(AUC). The measure of comparative accuracy is the trapezoidal approximation to the area under
the receiver operating characteristic curve. The area under this curve is a nonparametric measure
of discrimination. While squared error summarizes how close each individual’s survival
prediction is to the true outcome, the receiver operating characteristic area measures the relative
goodness of the set of predictions as a whole by comparing the predicted probability of each
individual with that of all pairs of individual s. This area is calculated using the predictive scores
of each algorithm in order to compare their average accuracy in predicting outcome. The receiver
operating characteristic area is independent of both the prior probability of each outcome and the
threshold cutoff for categorization, and its computation requires only that the algorithm produce
an ordinal-scaled relative predictive score. In terms of mortality, the receiver operating
characteristic area estimates the probability that the algorithm will assign a higher mortality
score to the patient who died than to the patient who lived. The receiver operating characteristic
area varies from 0 to 1. When the prognostic score is unrelated to survival, the score is 0.5,
indicating chance accuracy. The farther the scoreisfrom0.5, the better, on average, the prediction
model is at predicting which of the individuals who will survive. Positive predictive values
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(PPVs) refers to the chance that a positive test result will be correct, negative predictive value is
concerned only with negative test results. The interesting thing about positive and negative
predictive values is that they change if the prevalence of the disease changes. In fact, for any
diagnostic test, the positive predictive value will fall as the prevalence of the disease falls while
the negative predictive value will rise (94).
5.12 Breast Cancer stage classification using various activation functions
In traditional regression, a specific equation must be predetermined based on the data in
the system in order to find a relation between the inputs to output variable. Whereas the general
structure of an ANN can be applied practically on any system. Also, ANNs have been shown to
outperform regression models when outliers exist in the data and a MLP neural network with an
appropriate activation function in the hidden layer is always considered as a better model.

The objective of using MLP neural networks in this chapter is to be able to classify stages
of breast cancer data. In order to classify the stages we hves chosen MLP network as the
classifier. We designed different feed forward MLP networks with one hidden layer with
different inputs. One hidden layer MLP is almost always sufficient to approximate any
continuous function up to certain accuracy (95). It is proven in many situations that MLPs
possess the ability to learn and give the better performance especially in the case of
classification. The MLP network has to be trained before it able to perform specific task with
less error. In this study we used 33152 (70%) data for training, 14015 (30%) data for testing the
trained network.
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Table 5.2 Activation Functions

Activation function
Linear
Binary step

Ramp function or
Saturating linear

Definition
f ( x)  x

0, x  0
f ( x)  
1, x  0

 0, x  0

f ( x)   x,0  x  1
 1, x  1

1
1  ex

Uni polar Sigmoid

f  x 

Bi-polar

1  e x
f  x 
1  e x

Hyperbolic tangent

f  x 

e x  e x sinh( x)

e x  e x cosh( x)

𝑔(𝑥, 𝑐) = 𝑔(||𝑥 − 𝑐||)
Radial Basis Function

𝑁

𝑦(𝑥) = ∑ 𝑤𝑖 𝑔(||𝑥 − 𝑐𝑖 ||)
𝑖=1

In this study we compared the performance of an MLP network by using different
activation functions. Every MLP network consists of an input layer, hidden layer and an output
layer. For all the MLPs with different activation functions hidden nodes are selected
automatically based on the requirement for training. The best number of hidden nodes required
in the hidden layer depends on the number of inputs and outputs, amount of noise in the
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Table 5.3 Input Variables & types

Input

Modalities

Details

Real

1mm – 998mm

Variables
Tumor Size

1= No Treatment
Treatment

Categorical

2= Radiation
3=Radiation & Surgery
4= Surgery

Age
Number of
primary tumors

Real

21 - 102
1,2,3,4,5 = able to detect

Real

9 = not able to be detected
1=Well differentiated
2=Moderately differentiated

Grade

Categorical

3=Poorly differentiated
4=undifferentiated
9=Cell type not determined
1 = Single
2 = Married

Marital Status

Categorical

3 = Separated
4 = Divorced
5 = Widowed
9 = Unknown
1 = Whites

Race

Categorical

2 = African Americans
3 = Other races

Duration

Real

1-203 months

targets, activation function used. Rules of thumb don't usually work. The number of hidden
neurons decided upon training stage of the MLP networks. Four output neurons for four stage
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classification are needed to classify the class of the target outputs. The performances of the MLP
networks will be evaluated in terms of percentages for correct classification, defined as the
difference between the actual and the simulated results and by ROC analysis.
The work in this chapter is divided into two parts. In the first part we designed six neural
networks models using all combinations of activation functions with all the inputs including
tumor size, treatment, age, number of preliminary tumors, and grade of the tumor, marital status
and race of women to classify their stage of breast cancer. At the end of first part of work, our
objective is to find the best combination of activation function pair that classifies the breast
cancer stages, by comparing the number of hidden nodes, positive predictive values (PPVs),
percent of correct classification and comparing ROCs (96). Table 5.2 has the details of input
variables used in modeling the neural networks. After identifying the best activation function, in
our second part of work, we tried to reduce the neural network model by eliminating the inputs
which perform the least. Inputs which fall below 5% normalized importance are eliminated and
the networks are rerun to check the efficiency of the model.
For the first part, fixing Hyperbolic Tangent as the activation function for hidden layer,
we used softmax, hyperbolic tangent, sigmoid as the transfer functions in output layer. Later
fixing sigmoid function as activation function we have used the softmax, hyperbolic tangent,
sigmoid as the transfer functions in output layer. This resulted in total of 6 different models.
Results of 6 full models with the percentage of correct predictions, positive predicted
values (PPVs) during training and testing along with stage wise area under curve values are given
in Table 5.3 and Table 5.4. From these tables, the model with hyperbolic tangent and softmax
function has a better prediction with less number of hidden nodes. Figure 5.14 gives the ROC of
the selected model.
113

Table 5.4 Full Model stage classification probabilities

Positive Predictive Probabilities
Full Model details
Number
Overall
Training
of hidden P(1|1)
P(2|2)
P(3|3)
P(4|4)
Accuracy
units
HT– Softmax
8
88.9%
75.0%
41.9%
33.8%
79.0%
HT – HT
9
91.7%
73.7%
45.3%
26.3%
79.8%
HT – Sigmoid
9
90.4%
76.4%
0%
0%
77.0%
Sigmoid – Softmax
9
89.5%
74.5%
46%
26%
79.1%
Sigmoid – HT

9

90.6%

75.1%

40.7%

1.2%

79.0%

Sigmoid – Sigmoid

9

91.7%

73.7%

50.9%

0%

79.4%

Testing
HT– Softmax

8

88.9%

75.0%

39.3%

28.8%

78.8%

HT – HT

9

92.1%

72.7%

43.0%

26.1%

79.5%

HT – Sigmoid

9

90.9%

76.1%

0%

0%

77.6%

Sigmoid – Softmax

9

89.8%

74.5%

45.1%

23.7%

79.1%

Sigmoid – HT

9

90.8%

73.5%

43.1%

0.8%

78.5%

Sigmoid – Sigmoid

9

91.7%

72.5%

51.2%

0%

79.0%

HT-Hyperbolic Tangent
Figure 5.15 and Figure 5.16 are the performance analysis of PPVs for training and testing of
the full models. From these figures and the results given in Table 5.3 and Table 5.4, though the
sigmoid-softmax pair has comparatively same results like hyperbolic tangent-softmax pair, we
prefer to select hyperbolic tangent-softmax pair for the following reasons. A MLP model with the
best performance using less number of hidden units is considered as the best ANN representing
the problem. Hyperbolic tangent-softmax model uses only 8 hidden units whereas softmaxsigmoid network uses 9 hidden units. Also since the hyperbolic tangent activation function has a
derivative, it can be used with gradient descent based training methods. The hyperbolic tangent
activation function is perhaps the most common activation function used for neural networks. The
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hyperbolic tangent function provides similar scaling to the sigmoid activation function, however,
the hyperbolic tangent activation function has a range from -1 to 1. Because of this greater numeric
range the hyperbolic activation function is often used in place of the sigmoid activation function.
The neural network diagram for the selected full model is given in Figure 5.17.

Figure 5.14 ROC of the full model

Table 5.5 ROC values of full models

Activation
Functions
HT– Softmax
HT– HT
HT– Sigmoid
Sigmoid – Softmax
Sigmoid –HT
Sigmoid – Sigmoid
HT-Hyperbolic Tangent

AUROC Stages
1
0.911
0.910
0.910
0.912
0.909
0.910
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2
0.866
0.866
0.859
0.868
0.863
0.862

3
0.910
0.882
0.909
0.913
0.862
0.909

4
0.910
0.895
0.886
0.919
0.881
0.882

79.40%

91.70%

H – S

P(2|2)

S-SM

P(3|3)

P(4|4)

50.90%
0%

1.20%

0%
0%
HT – HT

P(1|1)

73.70%

40.70%

46%
26%

26.30%

79.00%

90.60%
75.10%

79.10%

89.50%
74.50%

45.30%

77.00%

90.40%
76.40%

79.80%

91.70%
73.70%

41.90%
33.80%

79.00%

88.90%
75.00%

HT – SM

S – HT

S – S

Overall Accuracy

Figure 5.15 Testing performance of full models

HT – HT

P(1|1)

79.00%

91.70%
51.20%

H – S

P(2|2)

S-SM

P(3|3)

P(4|4)

S – HT

Overall Accuracy

Figure 5.16 Testing performance of full models
HT-Hyperbolic Tangent; SM-Softmax; S-sigmoid
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0%

0.80%

0%
0%
HT – SM

72.50%

78.50%

90.80%

23.70%

43.10%

45.10%
26.10%

73.50%

79.10%

89.80%
74.50%

77.60%

90.90%
76.10%

79.50%

92.10%
72.70%
43.00%

39.30%
28.80%

75.00%

78.80%

88.90%

HT-Hyperbolic Tangent; SM-Softmax; S-sigmoid

S – S

Figure 5.17 Full MLP model using Hyperbolic tangent-softmax activation function
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5.13 Reduced Neural Network Model and Conclusion
After identifying that the neural network using the combination of hyperbolic tangentsoftmax pair as the best neural network model for breast cancer stage classification, we further
proceed to identify the reduced neural network model. Using the same activation pair selected
from full model we try to find reduced model, if any, by using fewer input units and/or hidden
units which can perform equivalent to full model or even better than the full model. In order to do
this, we rerun a neural network model by eliminating the input variables from the full model which
have less than 5% normalized importance in performance of breast cancer stage classification.

Table 5.6 Importance and Normalized Importance of input variables
HT – SM

HT – HT

HT – S

S – SM

S – HT

S–S

Inputs
Imp

N.Imp

Imp

N.Imp

Imp

N.Imp

Imp

N.Imp

Imp

N.Imp

Imp

N.Imp

M_STATUS

.021

3.8%

.064

14.6%

.090

15.3%

.025

4.2%

.037

7.6%

.040

6.9%

RACE

.018

3.4%

.016

3.6%

.018

3.1%

.018

3.0%

.013

2.7%

.016

2.8%

GRADE

.025

4.6%

.037

8.5%

.035

6.0%

.023

3.9%

.050

10.3%

.033

5.7%

TREATMENT

.127

23.4%

.150

34.3%

.069

11.7%

.111

18.7%

.134

27.6%

.110

19.3%

AGE

.059

10.9%

.106

24.3%

.095

16.2%

.048

8.1%

.103

21.3%

.118

20.7%

NUMPRIMS

.085

15.7%

.108

24.7%

.060

10.2%

.021

3.5%

.099

20.5%

.034

6.0%

TUMOR_SIZE

.543

100.0%

.437

100.0%

.586

100.0%

.593

100.0%

.484

100.0%

.573

100.0%

DURATION

.121

22.3%

.083

18.9%

.047

8.1%

.162

27.3%

.081

16.8%

.075

13.0%

From Table 5.5 for the selected activation pair of full model neural network, the input
variables race, marital status and grade are the variables fall below 5% normalized importance and
are eligible for elimination. Eliminating these input variables we modeled a reduced network
model to perform stage classification of breast cancer. The reduced model has 8 input variables, 6
hidden units to classify breast cancer stages compared with 22 inputs and 8 hidden units of full
model. An output equation of ANN will be a composite function given as

𝑦𝑖 = 𝑓 {∑ 𝑔 (∑(⦁))} ;
𝑤ℎ𝑒𝑟𝑒 𝑖 = 1,2,3,4; 𝑓(⦁) 𝑖𝑠 𝑡ℎ𝑒 𝑜𝑢𝑡𝑝𝑢𝑡 𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛 𝑎𝑛𝑑 𝑔(⦁)𝑖𝑠 𝑎 ℎ𝑖𝑑𝑑𝑒𝑛 𝑙𝑎𝑦𝑒𝑟 𝑜𝑢𝑡𝑐𝑜𝑚𝑒
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Table 5.7 Training and Testing results of the reduced neural network model

Positive Predictive Probabilities
Reduced
ANN
Overall
Model Architecture P(1|1)
P(2|2)
P(3|3)
P(4|4)
Accuracy
details
I–H–O
8-6-4
89.8%
74.2%
49.8%
30.3%
79.5%
Training
8-6-4
90.0%
73.5%
49.2%
24.9%
79.0%
Testing
I-Input units; H-Hidden units; O- Output units

Figure 5.18 ROC of the reduced neural network model

Table 5.8 ROC Comparison for Full and reduced models

Models
Stage-1
Reduced Model 0.911
0.911
Full Model

Stage-2
0.868
0.866

Stage-3
0.912
0.910

Stage-4
0.915
0.910

Table 5.6 has the results of reduced neural network architecture, positive predictive values,
and overall accuracy of training and testing classification results. The reduced model area under
curve and full model area under curve results are compared and presented in Table 5.7. Reduced
model works efficiently using 8 input units and 6 hidden units only. Figure 5.18 gives the ROC of
the reduced model. Reduced model performed almost close to the full model but with fewer units
in input and hidden layers. Clearly the reduced model with hyperbolic tangent-softmax activation
pair is opted as précised one for breast cancer stage classification.
119

CHAPTER SIX
A Comparison of Artificial Neural Network and Decision trees with Logistic Regression as
Classification Models for Breast Cancer Survival

6.1

Introduction
Computer models are being employed actively in the clinical diagnostic field to

differentiate between healthy and disease suffering patients. These computer models are
responsible in facilitation of making accurate decisions towards likelihood of disease based on
certain characteristics of the patient. Many different modeling techniques have been developed,
tested and refined. These techniques include both statistical (Linear Discriminant Analysis,
Logistic Analysis, etc.) and non-statistical techniques (Decision Trees, k-Nearest Neighbor,
Cluster Analysis, Neural Networks, etc.). Each technique utilizes different assumptions and may
or may not achieve similar results based upon the context of the data. Three of such models
developed are regression methods, decision trees and artificial neural networks. Regression
methods were termed as the study of dependence (97). This means it measures or calculates the
relationship between dependent variable and one or more independent variables. Regression
models are central part of many research projects. It has been used to predict the survival of
critical conditioned patients who are generally admitted to intensive care unit as a function of
physiological variables (98). Basically, regression models are classified into two main categories
i.e. linear models and logistic regression models. The logistic regression model is quite often
employed technique in data analysis. It is considered as a well-known classification modeling
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that allows probabilistic decisions and shows promising results on several problems. Like all
others regression models, which are used for description, control and prediction, logistic model
(also called as logit model) produce similar results with a best fitting which is considered as a
clinically interpretable model.
Survival analysis can be considered a classification problem in which the application of
machine-learning methods is appropriate. By establishing meaningful intervals of time according
to a particular situation, survival analysis can easily be seen as a classification problem. Survival
analysis methods deals with waiting time, i.e. time till occurrence of an event. Commonly used
method to classify this sort of data is logistic regression. Sometimes, the underlying assumptions
of the model are not true. In model building, choosing an appropriate model depends on
complexity and the characteristics of the data that affect the appropriateness of the model. Two
such strategies, which are used nowadays frequently, are artificial neural network (ANN) and
decision trees (DT), which needs a minimal assumption. This study aimed to compare
predictions of the ANN, DT and logistic models by breast cancer survival.
6.2 Questions of Interest
Q1: What are the significant attributable variables which play an important role in
classifying breast cancer survival?
Q2: What are the different models using different classification methods will be able to
give improved prediction of survival in breast cancer women?
Q3: Which of the following techniques will produce the model with the highest precision
in classifying the breast cancer survival data: logistic regression, decision trees, or neural
networks?
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Q4: How does ANN model and decision tree model perform compared with logistic
regression model in the analyses breast cancer survival using different input variables for the
same individuals?
Q5: Are there any benefits of Artificial Neural Network analyses (ANN) and decision
tree models compared with logistic regression analyses?
Q6: Using the identified model, what is the probability of survived subject is correctly
classified as survived and not survived woman as not survived?
Q7: Will the model selection vary based on the selected evaluation method?

6.3 Logistic Regression
The linear logistic regression assumes that natural logarithm of odds is in linear
relationship with corresponding independent covariates. The linear logistic function is
characterized by three main components. They are random experiment (identifies the PDF of
response variable), a systematic component (linear relationship of explanatory variables which
are used as predictors), link function (describes relationship between the first and second
components). The logistic regression is distinguished from linear model based on its binary
outcome. Logistic model is a type of predictive model which relates two categories of variables
like dependent variables (dichotomous or binary outcome either 0 or 1) and independent
variables (predictor or explanatory variables). In the binary response model, an individual takes
one of the two possible outcomes. Some of the expected binary outcomes are active-inactive,
healthy-unhealthy, normal-abnormal etc. For example the probability of officer promotion would
relate to his characteristics like annual performance and CEP. This model estimates or predicts
by fitting the occurrence of events into logistic curve. A broad choice of aspects using various
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links functions that describe the relationship between the probability distribution of response
variables and the linearity of explanatory variables are listed below.
1. The logistic function:

𝑔1 (𝜋) = 𝑙𝑜𝑔 {𝜋/(1 − 𝜋)}

2. The inverse normal function:

𝑔2 (𝜋) = Ф − 1 (𝜋)

3. The complementary log – log function: 𝑔3 (𝜋) = −𝑙𝑜𝑔 {−𝑙𝑜𝑔 (1 − 𝜋)}
4. The log – log function: 𝑔4 (𝜋) = −𝑙𝑜𝑔 {−𝑙𝑜𝑔 (𝜋)}
Apart from this logistic function also possess one important characteristic feature is its
overall transformations in that it is eminently suited for analysis of data collected. Logistic
regression architecture is given in Figure 6.1. For example, one can try to predict whether a
subject will suffer from heart attack at a specified time based on certain characteristics like
person age, sex, habitats etc. Logistic regression is extensively used in medical diagnosis like
brain injury, different types of cancer prediction like breast, cervical, prostate etc. More details
can be found in text book Applied Logistic Regression of Hosmer and Lemeshow (99). Example
of logistic curve is shown in Figure 6.2.
Parameter
Estimation

V

𝑓(𝑥)

Observed

Test Sample

Sample

Figure 6.1 Architecture of Logistic regression
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Figure 6.2 Logistic Curve

In case of polytomous response model, the response of a specific item or individual is
restricted to only a fixed set of possible values. The binary response model falls under the
category of polytomous response model as a special case. The logit models utilize the ordering of
response variables by nature. One such example is usage of rating scales in testing of food and
wine tasting.
McFadden (100) was the first person who linked the multinomial logit function to theory
of mathematical psychology and received Nobel Prize in 2000. And many more articles in the
21st century have made their own and unique way of importance to logistic regression. At present
wide range of applications using logistic function are being explored in various fields like
medicine, biological sciences, sociology, psychology, business, management etc.
In our present work, the outcome variable, survival prediction with breast cancer or
otherwise is predicted from the knowledge of the patient’s age, tumor size, stage of cancer,
treatment, administered and duration.
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6.4 Timeline of Logistic Function
6.4.1: 19th Century
Alphonse Quetelet (1795-1874), Belgian astronomer turned statistician was first person
who extrapolated the exponential growth of human population. Pierre-Francois Verhulst (18041847) derived the expression and named the expression as ‘Logit function’ (102). He included
the expression, functions, properties and applications in three papers published at Proceedings of
the Belgian Royal Academy (101).
6.4.2: 20th Century
1920-1930
Until 1920 there are no specific articles or reviews that discuss about logistic functions.
Raymond Pearl and Lowell J Reed (1920) were the persons who discovered the logistic function
for the study of population growth of United States of America. The curve gave a good fit for
population during the period of 1790 to 1910. They do not have the knowledge of Verhulst
works on Logit function. Berkson and Reed (1929) published papers on the application of logit
function (103) to autocatalytic reactions in Proceedings of the National Science Academy of
Sciences. Yule (1925) was the first person who provoked the name of logit function and
appreciated the works of Verhulst in his papers in Yule’s Presidential Address of the Royal
Statistical Society (104).
1930-1940
Gaddum and Bliss (1933-1934) introduced the probit model also called as “Probability
Unit”. But the authors gave more importance to logarithmic transformations rather than common
normal distributions in bioassay for the study of stimulus and its responses.
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1940-1950
Berkson (1944) was the first person who substituted ‘Probit’ with ‘Logit’ by conducting
many experiments on the method of maximum likelihood estimation and its advocacy in
minimum chi-square estimation which were not approved at that time (105).Wilson(1943)was
probably the first person to publish as application of the logistic function in bioassay in Wilson
and Worcester.
1960-1970
Cox (1960-1970) gave equal importance to logit functions compared with probit
functions in his articles published in JSTOR electronic repertory, which is one among the 12
major statistical journals in the English language. He covered the importance of multinomial
generalization of logit function (37).
1970-1980
Mckelvey and Zavoina (1975) formulated the latent regression model for an ordered
probit model of the voting behavior of United States congressmen (106). In 1977 BDR
(Biomedical Data Processing) which is a computer package offered the facility of maximum
likelihood estimation of logit and probit functions.

6.4.3: Recent Trends
Ever since the demand for logistic regression has increased tremendously, many articles
in name and application of function evolved in many international journals. Few of much cited
works are listed below for reference.
1991: The Importance of Assessing the fit of Logistic Regression Models (106).
1993: Nontraditional Regression Analysis (107)
1995: Regression Shrinkage and Selection via the Lasso (108)
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1997: A Comparison of Goodness-of-Fit tests for the Logistic Regression Models (109).
1999: Additive Logistic Regression: A Statistical View of Boosting (110).

6.4.4 Underlying assumptions
There were many numbers of assumptions made to the logistic regression compared to ordinary
regression methods.
8. The data collected is assumed to be completely randomized during the assignment of
treatments to experimental subjects.
9. Multinomial logistic regression does not consider the sample size estimations and
identifications of outliers.
10. The attracting aspect of multinomial logistic regression analysis is, it does not assume
normality, linearity and homoscedasticity. In order to meet the requirements multinomial
logistic regression is subjected to discriminant analysis because this analysis does not have
any presumed assumptions.
11. The assumption of independent variables by logit function can be tested by McFaddenHausman test (111).
12. Furthermore, Multinomial logistic regression assumes non-perfect separation which means if
the outcomes of variables can be separated by predictor variables then unrealistic coefficients
appear which influence the size.

6.4.5 Fitting the Logistic Regression Model and Significance Tests
Consider a sample size of n with observations 𝑥1 , 𝑥2 , 𝑥3 , … . 𝑥𝑛 which denote the predictor
variables that produce the binary output either Y=0 (absence) or Y=1(presence) of the disease.
‘Y’ represents the dichotomous outcome variable corresponding to the xi value of the 𝑖 𝑡ℎ variable.
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Assuming each of these variables is at least scaled interval, the conditional probability that is
present denoted by 𝑃(𝑌 = 1|𝑥) = 𝜋 (𝑥) where π denotes the probability of disease is present.
The probability of outcome is related to the potential predictor variables by the equation of the
form
𝑙𝑜𝑔𝑖𝑡 [𝜋(𝑥)] = 𝑙𝑜𝑔

𝜋 (𝑥)

1 − 𝜋 (𝑥)

= 𝛼 + 𝛽1 𝑥1 + 𝛽2 𝑥2 + … … + 𝛽𝑘 𝑥𝑘

Where(𝛼, 𝛽1 , 𝛽2 … 𝛽𝑛 ) are termed as the regression coefficients of the predictor variables
(𝑥1, 𝑥2, 𝑥3 … . 𝑥𝑛 ). The coefficients of regression are extracted from the availability of data. The

regression coefficients measure the percentage of contribution of predictor variables towards the
outcome. This prediction is generally followed by the odds ratio of independent variable. The
odds ratio is estimated by taking the exponential ratio of the coefficient (say:𝑒𝑥𝑝 (𝛽1)). For
example the odds ratio for breast cancer can be estimated by taking into consideration the age as
independent variable along with exponential function of regression coefficient. This estimation
represents the likelihood of occurrence of breast cancer based on age. The use of probability
values determines the importance of variables in terms of statistical significance in producing
outcomes. Increasing the sample size, predictors with small effects on the outcomes become
statistically significant. Hence, the selection of significant variables is important in such a
prediction. This selection is usually compelled either by forward or backward selection or stepwise selection depending upon the size of the sample. Sometimes clinically important variables
may show statistically insignificant prediction of outcomes due to influence of strong predictors.
In such case the criterion level of significance can be increased to avoid conflicts.
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6.4.6 Survival prediction using Logistic, ANN and Decision tree modeling
In this chapter, using the same input and output variables we established four models
using both logistic regression, ANNs, decision trees and compared their performances.
Event history models and logistic regression models are the two commonly used analyses
of survival, where the former models use target survival as a continuous variable of survival
time, while the latter models use a fixed survival length. The target is thus a dichotomous
variable, survived or not. In this chapter, using logistic regression model as a classifier we
predict the survival of breast cancer women.
The main idea of this chapter is to design four models with significant attributable
variables to predict the survival of a breast cancer woman. The significant independent variables
used in this modeling are selected by logistic regression analysis. As discussed earlier, logistic
regression is a statistical technique used to examine the relationship between a dependent
variable (survival or otherwise) and a one or more independent variables (numerical or
categorical). Initially, we have used all the independent variables including: tumor size, age,
stage of cancer, treatment, duration, grade of tumor, race, marital status, and number of primary
tumors. Based on the logistic regression results the independent variables grade of tumor, race,
marital status, and number of primary tumors nor their interaction terms were not statistically
significant in providing the best prediction of survival of breast cancer women. Leaving these
insignificant variables out of the modeling we designed four models inputting one variable at a
time. The output vector in these models contains two variables for each case: predicted survival
either 0 (not survived/dead) or 1 (survived/alive). A number between 0 and 1 gives an estimate
of the accuracy of the predicted value.
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The first model, named model-1 is using two variables including: age and tumor size
only. The second model, named model-2 is using three variables including: age, tumor size, and
stage of cancer. The third model, namely model-3 includes treatment along with the three
variables chosen in model-2. The last model, model-4 has the variables including: age, tumor
size, and stage of cancer, treatment and duration. In all these models our output is to predict the
survival or otherwise of a breast cancer women. We interpret this overall accuracy, as a measure
of the reliability of a given estimate.
Table 6.1 summarizes the specificity, sensitivity and overall accuracy results of the four
logistic regression models. Table 6.2 has the ROC area values for the four logistic models. The
results showed that the overall accuracy jumps from 70.42% for model-3 to 80% for model-4.
This is not a surprising result. As anticipated, duration of stay for a woman with breast cancer,
during the study period has a lot of importance for predicting accurate survival. The logistic
regression model-1 yielded a ROC area of 68.8%, and sensitivity to survival of 95% gave a
specificity of only 25%, model-2 with a ROC area of 71% and sensitivity to survival of 95% has
a specificity of 30%. For the remaining two models the ROC area is 71.8% and 85.5%
respectively and the sensitivity to survival of 95% has a specificity of 29% and 61% respectively.
The results of model-4 logistic regression providing with overall accuracy of 80% along with
81.54% specificity, 76.82% sensitivity and 61% specificity at 95% sensitivity is often desirable.
The sensitivity and specificity of all the four models with their respective confidence intervals
are given in Table 6.1. For computing confidence intervals for sensitivity and specificity see
Altman et al. The ROC graphs of the four logistic models are given in Figure 6.3.

130

Table 6.1 Sensitivity, specificity and overall results of Logistic regression models

Logistic
Regression
Model
LR 1
LR 2
LR 3
LR 4

Sensitivity (%)
value
95% C.I

Specificity (%)
value
95% C.I

Accuracy
(%)

68.01
67.31
67.69
76.82

69.45
70.47
71.26
81.54

69.2
69.78
70.42
79.98

(67.04, 68.96)
(66.39, 68.21)
(66.80, 68.55)
(76.14, 77.47)

(68.99, 69.91)
(70.0, 70.93)
(70.78, 71.72)
(81.11, 81.97)

Table 6.2 LR models ROC area values

LR
Models

ROC

LR-1
LR-2
LR-3
LR-4

68.8%
71.0%
71.8%
85.5%

LR-1

At 95%
sensitivity
Specificity
25%
30%
29%
61%

LR-2

131

LR-3

LR-4

Figure 6.3 ROC graphs for four LR models

6.5 ANN Perceptron Classification
Major amount of research works during 1960’s were carried under the name of
“Perceptron”. Frank Rosenblatt (1958) was the person who coined the term “Perceptron” in his
psychological magazine (112). The word perceptron is derived from English word “Perception”
which means ability of an individual to understand. He has written in his book named
“Principles of Neurodynamics” on how to train these kinds of neurons to enable them perform
pattern recognition tasks. He further provided information on how perceptron provide solution to
particular problem in finite number of steps. The perceptron turns out to be McCulloch-Pitts
model which mean a neuron with weighted outputs and with additional pre-processing.

6.5.1 Definition of Perceptron
A perceptron can be termed as a classification of different sets of data probably unseen
data sets into learned ones. The structure of perceptron possesses a number of inputs, a bias and
an output. A simple schematic diagram of perceptron is shown in Figure 6.4.

132

Figure 6.4 A simple perceptron

Another definition of perceptron can be considered as “An arrangement of one input
layer of McCulloh-Pits neurons feeding forward to one output layer of McCulloch-Pitts neurons
is known as perceptron”.
6.5.2 Multilayer Perceptron
The concept of multilayer perceptron is built using number of single layer neurons. Each
of the perceptron layers is used to solve nonlinearly separable problems by breaking them into
small linearly separable sections of inputs provided. The outputs of each individual perceptron is
extracted and combined with another series of perceptrons to obtain final output. In most cases
the hard-limiting function (step function) is used for producing outputs. This step function
prevents the information of the inputs to overflow into the inner neurons. To solve this problem
step function is replaced with a sigmoid function. In a multilayer perceptron, the neurons are
arranged in order of the input layer, one or more hidden layers and an output layer as shown in
Figure 6.5. The architecture (113) is designed to possess better properties like no direct
connection between input and output layers, full connection between layers, number of outputs
need not be equal to number of inputs, there is no limit for number of hidden layers i.e. they can
be more or less than input and output units.
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Input Units

Hidden Units

Output Units

Figure 6.5 A simple feed forward perceptron model

ADALINE is an acronym for ADAtive LINear Element. Bernard Widrow and Marcian
Hoff (1960) developed and presented this as single staged network. It is also called as the delta
rule; the least-mean-squares rule; the Widrow Hoff rule. The binary values for input and output
were assumed to be -1 and +1 respectively. Adaline possess similar architecture to perceptron,
but the difference lies in type of learning rule used and thresholding step. These enable the user
to solve the linearly inseparable problems which is impossible with single layer perceptron. The
Widrow-Hoff learning (114) is applicable for trained supervisor, it is independent of the
activation functions of neurons used. The LMS algorithm was proposed for Adaline. It is evident
from above that training of perceptron requires modification of weights. The delta rule states that
weights need to be adjusted corresponding to difference between desired and actual output.

6.5.3 Introduction to Back Propagation
The most widely used search technique for training artificial neural networks is back
propagation. This can also be termed as “Feed-Forward back-propagation network”. This is a
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user friendly model which can be understandable and implemented as software simulation. The
development of the back propagation training algorithm was credited to Werbos (1993), Parker
(1985) and LeCun (1986). It is considered as the most widely used learning which is easy to
implement and train. Rumelhart, Hinton and Williams have made important contributions
towards the development and analysis of back propagation (115). They have concentrated on the
improvement of the original back propagation algorithm. The attempts include working on
different strategies like scaling differentiation, error metric modification, transfer modification,
architectural restructuring, and constraining the solution set of the problem.
The Back propagation is a local search technique which is still a popular and successful
tool. It requires training for conditioning the network before used for processing other data.
Networks possess one or more hidden layers depending upon the training introduced. Supervised
training provides preliminary adjustments to the weights associated to organize the patterns
categorically. Even though BP is most popular optimizing method to train networks it has certain
limitations like inconsistency and unpredictable performances. The gradient nature of BP could
be eliminated by using global search techniques which do not depend on their derivatives. There
are some cases where large networks can take long time to be trained and may not converge to
solution significantly. The building of neural network ideal to brain is impossible. However we
can build some simpler artificial neural networks with a suitable transfer function to work almost
similar to a biological neuron. The functions of neural network built works similar in meaning to
the human brain.
The Feed Forward, Back-Propagation architecture (116) was developed in the early
1970’s by various independent sources (Werbor; Parker; Rumelhart, Hinton and Williams). In
Feed-Forward propagation, neurons in present layer receive signals from preceding layers which
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is multiplied by corresponding weights separately. Inputs from one or more previous neurons are
individually weighted, then summed. The entire uniqueness of the network exists in the values of
the weights between neurons. For this type of network in order to adjust weights the most
common learning algorithm is called back propagation (BP).The use of term “Back Propagation”
appears to be evolved after 1986 when researchers have presented their research of results on
Parallel Distributed Processing (PDP) models. This synergistically developed back-propagation
architecture which is most effective and easy to learn model for multilayer networks. Some work
has been done which indicates that a maximum of five layers, one input layer, three hidden
layers and an output layer are required to solve problems of complexity.
6.5.3.1 Training with back propagation
The problems are classified into training, testing and validation, files in the description of
data sets. A BP network will search for a solution using the training data, if the error decreases
during the testing & validation step, the training will discontinue. The researchers believe this
step is necessary to not over fit a particular function being estimated. The problem of the
algorithm begins with convergence. It may either converge to local or global solution. If a
correct objective function is chosen and a global solution is obtained, then there will no such
problem. Since, BP converges locally this type of NN training seems to be necessary. Learning
rate (training parameter that controls the size of weight and bias changes during learning) and
momentum coefficient (used to prevent the system from converging to a local minimum or
saddle point) are the key factors that will help a network to train. Too low a learning rate makes
the network learn very slowly. Too high a learning rate makes the weights and objective function
diverge, so there is no learning at all. In training our networks we set the learning rate as 0.15
and the momentum as 0.8.
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6.5.3.2 Back-Propagation Algorithm
A gradient search technique (117) like BP can provide the user with well recognized
problem such as escaping local optima. The weights which are initialized randomly during
training and starting point is located in local valley with high probability. Numerous solutions
have been proposed to problems like differential scaling, the transfer function etc. assuming
many different random starting points. A user must be able to choose different parameters to
apply in neural networks software packages. The parameters include step size, momentum,
learning rule, normalization technique, random seed etc. to find best combination to solve a
particular problem. For the training of multilayer feed-forward ANNs, Error-Back propagation
algorithm plays an important role. Generally the input layer is considered as a just distributor of
signals from the external world and not taken into consideration as a layer.
The back propagation training consists of two methods of computation:
1. A forward pass
2. A backward pass
In forward pass an input pattern vector to the units in the input layer basically leads to the
sensory nodes of the network. The signals from the input layer then propagate to series of layers
finally producing the output. This process continuous until the signals reach output layer where
actual response of the network to the input vector is obtained. In the backward pass, the synaptic
weights are adjusted according to the signal which propagated backwards to the direction of the
synaptic connections.
6.5.3.3 Implementing Back Propagation
The back propagation algorithm can be implemented in two different modes:
1.

On-line mode
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2.

Batch mode
In the on-line mode the error function is calculated after the presentation of the input

pattern and the error signal is propagated back through the network modifying the weights before
the presentations of the next pattern. The error function is generally the Mean Square Error of the
difference between the desired and the actual responses of the network. All such presentations of
such patterns is usually called as an epoch or one iteration. In batch mode the weights are
modified only when the input pattern have been presented. Then the error function is calculated
as the sum of the individual MSE for each of the input pattern and weights are modified
accordingly before the next iteration.
6.5.4 Error functions
If a pattern is submitted and its classification or association is determined to be
erroneous, the synaptic weights as well as the thresholds are adjusted so that the current least
mean square classification error is reduced. The input - output mapping, comparison of target
and actual values, and adjustment, if needed, continue until all mapping examples from the
training set are learned within an acceptable overall error. Usually, mapping error is cumulative
and computed over the full training set. Error is the measure of the discrepancy between the
neural network output and the target. The most popular error functions are sum of squares (SSE)
and cross entropy (CE) among others.

6.5.5 Advantages of Multilayer Perceptrons
The general characteristics of multilayer perceptrons are generalization and fault
tolerance.
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Generalization: Neural networks are capable of classifying unknown patterns with the support of
known patterns that have some different level of features. This means incomplete inputs will be
classified because of their similarity with complete inputs.
Fault Tolerance: Neural networks are highly fault tolerant. This characteristic feature can also be
termed as “graceful degradation” (118). Hence the neural networks keep on working even if
some interconnections between some neurons fail.

6.5.6 Limitations of Multilayer Perceptrons
There are limitations to the feed forward, back propagation architecture. Backpropagation requires a lot of supervised training, with lots of input-output examples. Sometimes,
the learning can get stuck in local minima, limiting the best solution. This occurs when the
network systems finds an error that is lower than the surrounding possibilities but does not
finally gets to the smallest possible error. In typical feed forward, back-propagation applications,
the desired output may not be known precisely. In such case the back propagation learning
cannot be used directly. Examples like include speech synthesis from the text robot arms,
evaluation of bank loans, image processing etc.
6.5.7 ANN Modeling
Neural networks are undoubtedly powerful nonlinear function estimators. As mentioned
earlier there are several types of ANN architectures. They usually perform prediction tasks at
least as well as other techniques, if not significantly better. Additionally, building an ANN
requires minimum domain knowledge in the areas of mathematics and statistics, than does for
building a logistic regression model. The ANN type used in this study is called a multilayer
perceptron (MLP) or multilayer feed forward network, which propagates input signals forwards
and error signals backwards. During the process, the weights are adjusted so that the output
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grows more accurate. This process is prone to over fitting problems. In order to avoid over
fitting, a common technique is to train the network with some portion of the data values, and
then evaluate its performance by testing the trained network with the remaining data values. In
our ANN modeling we used 70% data for training and remaining 30% data for testing.
The four ANN models consisted of an input layer, a hidden layer and an output layer.
Table 6.3 summarizes the specificity, sensitivity and overall accuracy results of the ANN models
when training. Table 6.4 summarizes the specificity, sensitivity and overall accuracy results of
the ANN models when testing the trained model. Table 6.5 has the ROC area values for the four
ANN models. Since training is the key factor for an ANN model, here we will be discussing
about training results of ANN models. Even in this case, the results showed that the overall
accuracy jumps from 71.12% for model-3 to 82.80% for model-4 for the same reason as
mentioned earlier. The ANN model-1 yielded a ROC area of 72.1%, and sensitivity to survival of
95% gave a specificity of only 31%, model-2 with a ROC area of 73.1% and sensitivity to
survival of 95% has a specificity of 32%. For the remaining two models the ROC area is 73.8%
and 87.4% respectively and the sensitivity to survival of 95% has a specificity of 39% and 66%
respectively. Comparing these results with logistic models, at a 95% sensitivity, ANN has a
better specificity for all the four models. Table 6.5 gives the details about architecture and ROC
area of ANN models and their respective ROC graphs of the four ANN models are given in
Figure 6.7. The output of ANN will be a composite function of the form
𝑦𝑖 = 𝑓 {∑ 𝑡𝑎𝑛ℎ (∑(⦁))} ; 𝑖 = 0,1;
𝑓(⦁) 𝑖𝑠 𝑎 𝑠𝑜𝑓𝑡𝑚𝑎𝑥 𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛 𝑎𝑛𝑑 𝑡𝑎𝑛ℎ(⦁)𝑖𝑠 𝑎 ℎ𝑦𝑝𝑒𝑟𝑏𝑜𝑙𝑖𝑐 𝑡𝑎𝑛𝑔𝑒𝑛𝑡 𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛
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Table 6.3 Sensitivity, specificity and overall results of ANN training

ANN
Models

Sensitivity (%)

Specificity (%)

Value

95% C.I

Value

95% C.I

Accuracy
(%)

ANN 1
ANN 2
ANN 3
ANN 4

66.78
67.25
68.23
88.95

(65.70, 67.83)
(66.19, 68.27)
(67.20, 69.23)
(88.27, 89.59)

70.76
71.48
72.08
80.60

(70.19, 71.31)
(70.91, 72.03)
(71.51, 72.63)
(80.09, 81.09)

69.85
70.46
71.12
82.80

Table 6.4 ANN models architecture and ROC values

ANN
Models
ANN-1
ANN-2
ANN-3
ANN-4

Architecture
ROC

I–H-O
2–7–2
6–3–2
10 – 6 – 2
11 – 3 – 2

72.1%
73.1%
73.8%
87.4%

At 95%
sensitivity
Specificity
30%
32%
39%
66%

Table 6.5 Sensitivity, specificity and overall results of ANN testing

ANN
Model
ANN 1
ANN 2
ANN 3
ANN 4

Sensitivity (%)

Specificity (%)

value

95% C.I

value

95% C.I

Accuracy
(%)

66.18
68.66
66.87
89.36

(64.52, 67.80)
(67.08, 70.20)
(65.26, 68.43)
(88.32, 90.32)

70.66
72.00
71.89
80.97

(69.79, 71.51)
(71.14, 72.84)
(58.27, 59.97)
(80.20, 81.72)

69.63
71.20
70.67
83.20
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ANN-1
ANN-2

ANN-4

ANN-3

Figure 6.6 ROC graphs for four ANN models

6.6 Decision Tree Classification
Data mining tools are proved to be successful in field of medical diagnosis. The
combination of both data mining tools along with decision trees is popular and effective
classification approach which provides understandable and clear classifications rules that transfer
knowledge to physicians and medical specialists. Data mining methods help to reduce the false
positive and false negative decisions (129-131). This is one of the actively employed techniques
that provide promising results in the breast cancer diagnosis.
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A decision tree can be stated as the classification tool or classifier for determining
appropriate action for the given situation. A simple decision tree consists of a root node (parental
node), internal nodes or test nodes, and leaf nodes (terminal nodes or decision nodes). The final
decisions for the target class are obtained on the leaf nodes from performing split test in the
internal nodes. In complex cases, the leaf node possesses a probability vector for the target value
of certain case (132). A simple decision tree classifying survival of breast cancer patients with
treatment as an attributable variable is given below Figure 6.7.

Figure 6.7 Simple Decision Tree example

Decision tree usually consists of nominal and/or continuous attributes. In case of nominal
attributes, one outcome is assigned for the target value whereas for continuous attributes there
will be threshold which has two outcomes, one for each classified interval based on the
conditions imposed by the fixed threshold. A more comprehensible decision trees are typically
less complex preferred by the decision makers. Each designated path of the decision tree from
root to leaf can be transformed into a rule by computing tests along the path which assign class
prediction to terminal node. These predictions are termed as the class values.
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6.6.1 Framework of Decision Trees: Algorithm
Decision tree accuracy is affected by the total number of nodes, depth of the tree, total
number of leaves and number of attributes used. The complexity is controlled explicitly by the
stopping criteria used and pruning methods employed. The objective of the decision trees is to
find the optimal decision tree by minimizing the general errors. In order to solve heuristic
problems with large data sets decision tree inducers with growing and pruning are being actively
employed. The algorithms employed follow the concept of “divide and rule” in evaluating for
the final optimal decision tree. In the foregoing process, partition of the training sets is executed
based in the values of the discrete attributes. The appropriate function is selected based on the
splitting measures. After the selection, nodes are further divided into subsections to carry out
similar splitting procedures or stopped when the criteria is satisfied (133, 134).
6.6.2 Splitting Techniques
Decision trees are most commonly univariate splitting i.e., they make splitting measures
based on the single attribute at each internal node. But, the inducer searches for the best attribute
at internal node upon splitting. Various criteria contain measures for the splitting procedures to
be executed. The splitting procedures are employed in different ways based on the originating
measure (includes information theory, dependence and distance) and based on the measure of
structure (impurity based criteria, normalized impurity based criteria, and binary criteria) more of
which can be found in data mining books (135). In case of univariate splitting, many researchers
claim that the choice of splitting criteria does not make much difference on the performance of
the tree.
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Accordingly in the literature multivariate splits have been extensively employed in case
complex decision making situations. The frame work for these splits is not well known as that of
univariate splits. Several attributes are involved in the single node split test at each internal node.
Generally, multivariate splits are based on the linear combination of the input variables. The
problem of finding the optimal linear split is much more difficult than that of the univariate split.
Methods used for finding optimal split include greedy search method (136), linear programming
(137), linear discriminant analysis (138), and many others.
6.6.3 Stopping Criteria
All the decision trees require stopping criteria otherwise it would be an undesirable to
grow a tree which occupies its own node. This would lead to expensive computation and
difficulty in interpretation. Rules for stopping the growing phase are discussed below.
1.

Number of cases in the node is less than the pre-indicated value.

2.

The depth of the node should not exceed more that predefined or maximum value.

3.

The number of cases in the terminal nodes is less than the minimum number of cases for
parent nodes.

4.

The best splitting should not exceed a certain threshold limit set.

5.

Predictor values for all records are identical – no further rule for splitting is computed.
6.6.4 Pruning Methods
Early studies have proved stopping criteria degrade the performance of tree. This might

create small and under fitted trees or over-fitted trees depending on situations. Hence, an
alternative method for stopping growth is to allow the tree to grow and prune back to the
optimum size using certain pruning methods. Pruning methods gained importance based on
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trading accuracy for simplicity. It has improved the generalized performance of the decision tree
especially in noisy circumstances (139). There are various techniques for pruning the trees
include cost-complexion, reduced and minimum error, pessimistic, optimal etc.
6.6.5 Decision Tree Inducers
The approach of induction is to develop a decision tree from set of examples. Various
techniques like ID3, C4.5, Classification and regression trees (CART or CRT), chi-squared
automatic interaction detector (CHAID), Quick, unbiased, efficient, and statistical tree (QUEST)
and many others are actively employed based on the attributes. For large data sets two methods
developed have been popularly employed namely the Catlett method and SLIQ algorithm.
Further advancements and extensions for decision trees like oblivious trees (140), fuzzy decision
trees, and incremental induction (141) can be found in the literature. Here in this chapter we will
construct decision trees based on CHAID and CRT methods and choose the best performing
method.
6.6.6 Chi-squared Automatic Interaction Detector (CHAID)
CHAID is a type of decision tree technique, based upon adjusted significance testing
(Bonferroni testing). It is one of the oldest tree classification methods originally proposed by
Kass (1980; according to Ripley, 1996, the CHAID algorithm is a descendent of THAID
developed by Morgan and Messenger). . CHAID algorithm only accepts nominal or ordinal
categorical predictors. When predictors are continuous, they are transformed into ordinal
predictors before using the following algorithm. After the merging of the continuous and
categorical variables adjusted p-value is computed using Bonferroni adjustments (14). P-value
decides further merging operation if needed or not.
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6.6.7 Classification and Regression Trees (CART)
CART algorithm was introduced in Breiman in 1986. These trees are characterized by the
construction of binary trees implies that each external nodes consists of exactly two outgoing
edges. It generates a regression model when the target variable is continuous else a classification
model in case of categorical variables. In case of regression models, the CART looks for the
splits that minimize the prediction square error (8). The prediction is based on the mean value of
the target attribute of the rows falling under the terminal leaf node. The present research studies
have employed these two methods which appeared to give better results compared to other
evaluation methods.
6.6.8 Advantages and Disadvantages
Decision trees were pointed as good classification tools in literature due to its selfexplanatory nature and easy to understand and interpretation behavior. It takes into consideration
both numerical and nominal input attributes. They have the capability to handle and deal with
large datasets and datasets with large amount of errors. The predicted performance is proved to
be much higher and better than traditional methods like neural networks, logistic methods etc.
Decision trees also possess certain disadvantages which include its sensitiveness to small
changes in input data can alter the nature of trees. Most of the algorithms accept only discrete
variables (like ID3 and C4.5). Decision trees perform well if few highly relevant attributes are
present and less if more complexions interactions exists.
6.6.9 Modeling using Decision Trees
Table 6.6 summarizes the specificity, sensitivity and overall accuracy results of the four
decision tree models using both CHAID and CRT based methods. Table 6.7 has the ROC area
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values for these models. The results showed that the overall accuracy jumps from 71.10% for
model-3 to 82.6% for model-4 in a CHAID decision tree. Similarly for a CRT based decision
tree the accuracy jumps from 70.9% for model-3 to 83.2% for model-4. As noticed in both
logistic and ANN models, duration under study for a woman with breast cancer, during the study
period has a lot of importance for predicting accurate survival.
For CHAID based decision tree the ROC for model-1 covered an area of 72%, and
sensitivity to survival of 95% gave a specificity of only 22%, model-2 with a ROC area of 73.2%
and sensitivity to survival of 95% has a specificity of 25%. For the remaining two models the
ROC area is 73.6% and 87.6% respectively and the sensitivity to survival of 95% has a
specificity of 29% and 62% respectively. The results of model-4 decision tree with overall
accuracy of 82.6% along with 80.14% specificity, 89.67% sensitivity and 62% specificity at 95%
sensitivity are often desirable. The sensitivity and specificity of all the four models with their
respective confidence intervals are given in Table 6.6. For computing confidence intervals for
sensitivity and specificity see Altman et al. The ROC graphs of CHAID based decision tree
models are given in Figure 6.9.
The results of CRT based decision tree models reported a ROC of 71.9% for model-1,
and sensitivity to survival of 95% gave a specificity of only 24%, model-2 with a ROC area of
72.8% and sensitivity to survival of 95% has a specificity of 29%. For the remaining two models
the ROC area is 72.7% and 87.4% respectively and the sensitivity to survival of 95% has a
specificity of 28% and 62% respectively. The results of model-4 CRT decision tree with overall
accuracy of 82.2% along with 79.86% specificity, 93.62% sensitivity and 62% specificity at 95%
sensitivity are often desirable. The sensitivity and specificity of all the four models with their
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respective confidence intervals are given in Table 6.6. For computing confidence intervals for
sensitivity and specificity see Altman et al. The ROC graphs of CRT based decision tree models
are given in Figure 6.8.
CHAID uses multi way splits by default (meaning that a given current node is split into
more than two nodes), whereas CRT does binary splits (meaning each node is split into two subnodes only). This difference between CRT and the CHAID has even an effect on the tree structures.
In case of CHAID, trees sometimes look more like bushes. CHAID has been especially popular in
marketing and medical research, where segmentation or classification has many major applications.
Few more differences are listed below:



CHAID uses a p-value from a chi-square significance test to measure the desirability of a
split, while CRT uses the reduction of an impurity measure.



CHAID searches for multi-way splits, while CRT performs only binary splits.



CHAID uses a forward stopping rule to grow a tree, while CRT deliberately over fits and
uses validation data to prune back.



CHAID tree output is simple, short and easy to interpret, while CRT has a larger tree
structure.
Finally, one may prefer CHAID when the goal is to classify or understand the relationship

between a response variable and a set of explanatory variables, whereas CRT is better suited for
creating a regression model. In view of this, in this chapter we will choose CHAID over CRT for
survival classification of breast cancer woman.
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Table 6.6 Sensitivity, specificity and overall results of Decision trees

CHAID
CRT
CHAID
CRT
CHAID
CRT
CHAID
CRT

Sensitivity
Specificity
Accuracy
(%)
Value 95% CI
Value 95% CI
64.77 (63.73,65.8) 71.12 (70.60,71.73)
69.6
66.83 (65.74,67.91) 70.75 (70.19,71.30)
69.9
69.33 (68.27,70.37) 71.21 (70.65,71.76)
70.8
69.2 (68.14,70.24) 71.2 (70.63,71.74)
70.7
67.59 (66.58,68.59) 72.25 (71.69,72.81)
71.1
66.22 (65.22,67.21) 72.64 (72.07,73.20)
70.9
89.67 (89.00,90.30) 80.14 (79.63,80.63)
82.6
93.62 (93.05,94.14) 79.86 (79.35,80.35)
83.2

CHAID
CRT
CHAID
CRT
CHAID
CRT
CHAID
CRT

Sensitivity
Specificity
Accuracy
(%)
Value
95% CI
Value
95% CI
63.66 (62.07,65.22) 71.22 (70.35,72.09)
69.3
67.33 (65.66,68.97) 69.69 (68.83,70.55)
69.2
68.63 (66.97,70.24) 71.27 (70.40,72.12)
70.7
67.24 (65.56,68.87) 70.82 (69.95,71.67)
70
66.32 (64.75,67.85) 72.19 (71.31,73.04)
70.7
65.11 (63.55,66.65) 71.42 (70.54,72.28)
69.8
88.2 (87.10,89.21) 80.38 (79.61,81.14)
82.4
94.02 (93.19,94.76) 79.93 (79.16,80.69)
83.2

Training
Model 1
Model 2
Model 3
Model 4
Testing
Model 1
Model 2
Model 3
Model 4

Table 6.7 ROC of Decision tree using CHAID and CRT

CHAID

CRT

Model-1

72.0%

71.9%

Model-2

73.2%

72.8%

Model-3

73.6%

72.7%

Model-4

87.6%

87.4%

6.7 Performance Evaluation of models
In the context of predictive binary classification models, one of four outcomes is possible: (a)
a true positive (TP) – i.e., a survived subject is classified as “survived”; (b) a false positive (FP)
– i.e., a not survived subject is classified as “survived”; (c) a true negative (TN) – i.e., a not
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survived subject are classified as “not survived”; (d) a false negative (FN) – i.e., a not survived
subject is classified as “survived”.
The central concern of implementing different modeling applications in this chapter is to
identify which of the proposed techniques are actually improving predictive accuracy. An
improvement of even a fraction of a percent can translate into significant savings or increased
revenue.
The performances of logistic, ANN and decision tree models in this chapter are evaluated
based on the sensitivity, specificity, overall accuracy, and the area under curve values of each
model. Sensitivity is the proportion of true positives that are correctly identified by the model.
Specificity is the proportion of true negatives that are correctly identified by the model.
CHAID

CRT

Model-1

Model-2
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Model-3

Model-4

Figure 6.8 ROCs of Decision trees using CHAID and CRT

In other words, sensitivity refers to how good is the designed model is at correctly identifying
women who are dead with breast cancer and specificity refers to how good the designed model is
at correctly identifying women who have survived breast cancer (119). However, as a matter of
fact, reporting a high sensitivity is not necessarily a good thing, but it’s the specificity, which
should not be worse, which in turn can conclude the designed model as useless (120). Also, we
will compare the area under the ROC curve, which is a convenient way to compare different
predictive binary classification models when the analyst or decision maker has no information
regarding the costs or severity of classification errors. According to Thomas (2000), this
measurement is equivalent to the Gini index and the Mann-Whitney-Wilcoxon test statistic for
comparing two distributions (Hanley and McNeil) and is referred in the literature in many ways,
including AUC or AUCROC values.
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Many research studies have exhibited the importance of ANNs, decision trees, logistic
regression as predictor and classification tools in field of medical diagnosis. The works are
extended in the risk prediction in a variety of cancers like breast (121), prostate (122), liver
(123), ovarian (124), cervical (125), bladder (126), and skin cancer (127).
We will compare the results of four logistic models with the results of four ANN models
and decision tree models. The analytical description of designed neural network or the internal
working of the ANN models will not be our point of concentration however we will treat them as
black box which intakes input data and gives us the output.
Table 6.8 has the performance evaluation of logistic, ANN and decision tree techniques.
The overall accuracy for correct classification of survival of breast cancer women is almost the
same in ANN and decision tree techniques compared to logistic. However the specificity of the
model performance for logistic is slightly more than the ANN and decision trees. The ranking of
these methods based on their classification performances are also tabulated in Table 6.8. The
area under the curve ROC values of decision tree methods is slightly more compared to ANN
and logistic regression methods. Table 6.9 has the details of comparing ROCs of the three
different methods employed in this chapter with their ranking based on high ROC values.
Table 6.8 Performance Comparison of Logistic, ANN and Decision tree

Model

LR

1
2
3
4
Rank

69.2
69.78
70.42
79.98
III

Overall Accuracy
ANN
CHAID
Train Test Train Test
69.85 69.63 69.6
69.3
70.46 71.2
70.8
70.7
71.12 70.67 71.1
70.7
82.31 81.95 82.6
82.4
II
I
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LR
69.45
70.47
71.26
81.54
I

Specificity
ANN
CHAID
Train Test Train Test
70.76 70.66 71.17 71.22
71.48 72
68.63 71.27
72.08 71.89 72.25 72.19
79.76 79.22 80.14 80.4
III
II

Table 6.9 ROCs of all methods

Models

LR

ANN

DT

Model-1

68.8%

72.1%

72.0%

Model-2

71.0%

73.1%

73.2%

Model-3

71.8%

73.8%

73.6%

Model-4

85.5%

87.4%

87.6%

Rank

III

II

I

85
80
75
70
65
60
LR

ANN Training
Model 1

ANN Testing

Model 2

Model 3

DT Training

DT Testing

Model 4

LR-Logistic Regression; ANN-Artificial Neural Network; DT-Decision tree
Figure 6.9 Comparison of overall accuracy of LR and ANN models
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84
82
80
78
76
74
72
70
68
66
64
62
LR

ANN Training
Model 1

ANN Testing

Model 2

Model 3

DT Training

DT Testing

Model 4

LR-Logistic Regression; ANN-Artificial Neural Network; DT-Decision tree
Figure 6.10 Specificity comparison of LR and ANN models

Decision tree
LR
ANN
Reference line

Figure 6.11 Comparison of ROCs graphically for the three methods
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6.8 Conclusion and discussion
For maintaining consistency in comparing the models, we initially compared the accuracy
of logistic distribution and accuracy in ANN and decision tree models in classification of
survival of breast cancer data. Further we calculated the receiver operating characteristic (ROC)
curves, compared them visually and calculate the area under the curve for comparison (121). The
graph of comparison of three methods based on ROCs is given in Figure 6.11. Model-4 using the
inputs including age, tumor size, stage of cancer, treatment and duration performed well by
logistic, ANN and decision tree methods. The accuracy of classification for LR, ANN and DT
models is recorded as 79.98%, 82.31% and 82.6%. We find no much difference in these values
for ANN and DT methods. However, at 95% sensitivity ANN has reported a better specificity
compared to logistic and DT models. Using ROC analysis as a measure of discriminating ability
of logistic, ANN and decision tree models we have not found convincing proof that the use of
ANN model or decision tree models in general would increase the quality of the statistical
studies that use traditional tools such as logistic regression models.
In the present study, the effects of factors like age, tumor size, stage of cancer, treatment,
and on the survival of a woman with breast cancer were designed. Four models for logistic and
four models of ANN trained with gradient descent and four models of DT based on CHAID
algorithm have been evaluated. The degree of generalization or the precision of predictive ability
was measured for each logistic model, ANN model, decision tree model and their predictive
abilities were in the order of model-4 > model-3 > model-2 > model-1.
As mentioned earlier, there is no significant difference in performance between LR, ANN
model and decision tree models as measured by area under the ROC curve. Though all of them
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have almost same area under curve, the shapes of these curves were different. i.e., at a fixed
sensitivity, ANN’s and decision trees had higher specificity compared to LR. Figure 6.11 depicts
this fact.
In summary, it is hard to draw general conclusions regarding the performance or
superiority of one model over the other on the basis of findings presented in this chapter or
elsewhere, since the results for each of these studies are based on the specific kind of interest.
Each model has its advantages, and the selection of a model should be based on these advantages
and the intended purpose of the study. In this study, we conclude that ANN model-4 and decision
tree model-4 has a better predictive probability compared to logistic model and can be used as
the best for the modeling and prediction of breast cancer survival.
Well-performing ANN models can be used for predictions when there is an unknown
nonlinear relation between the independent variables and the dependent variables that is not well
understood by other tools like logistic regression.
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CHAPTER SEVEN
Conclusion and Future work

In this chapter we shall pose some possible extensions of the present research. This
chapter stands on the foundations built on Chapters 2, 3, 4, 5 and 6. We make necessary
connections between the methods employed in those chapters and report on ongoing work that
could not be included in this thesis.
In chapter two, we have used the Inverse Gaussian (IG) distribution for statistical
modeling of the breast cancer tumor sizes for the three race women. At the end of this chapter
grouping ages into groups of 5, we also stratified the number of women diagnosed with breast
cancer in different stages. As a future research, it would be of interest to develop a
statistical/mathematical model that identifies categorized age as the independent variable and
tumor size as the response variable. Having established such models which may be non-linear in
nature with a high degree of accuracy, namely, high R2 and adjusted R2 we can further proceed
to calculate the rate of change of tumor size along with age.
As a part of future research we plan to focus on the use of the kernel density estimation
method. In case if we do not have enough information to fit the probability distribution of the
parameters which behave as a random variable, we can proceed to investigate the applicability of
the kernel density estimation method to obtain the density function of the parameters.
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In chapters three and four, we have used the family of generalized extreme value
distribution and log-logistic models to statistically model the survival of breast cancer women
utilizing the available predictor variables for predictive purposes. As the part of future research,
if we are given with more relevant information on breast cancer such as family history, age at
first live birth, drinking and smoking habits, etc. we can be able to provide more compressive
understanding of breast cancer. As a matter of fact, with the increased number of highly
attributable variables and very handy software programs, it is of paramount importance that a
survival model, incorporating such covariates be developed for more accurate and appropriate
results of prediction.
For the problem of breast cancer stage classification and classification of survival or
otherwise of breast cancer woman we proposed artificial neural network approach in chapters
five and six. There are many areas of research that can be explored further based on the findings
from these chapters. Some specific ideas for future research are listed below:
o The neural network parameters needs a random initializations of weights and
biases Failing to declare proper initial values can in turn reduce the chances of
proper training of network. Our proposal is to identify a relation, if any, that
define neural network parameters such as weights and biases in terms of
regression coefficients in statistical modeling.
o Try to identify and explore the black box nature of ANNs.
o Examine other network parameters that influence ANN performance, such as the
activation function, number of hidden layers, number of epochs, learning rate, etc.
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o To identify if there is any relationship between number of hidden layers, number
of hidden units in each hidden layer and the output function of the network. This
can mainly help us to reduce the training time.
o Evaluate the application of different activation functions mathematically and
statistically to identify their ability to provide robust results.
o Linking ANNs, regression, differential equations and implementing them in
applications of biological systems.
Finally, the methods used in the current study could be implemented in the study of other
types of cancers in providing important information on treatment and survival of cancer patients.
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